ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000085.1|Lankamycin_1 # 1 # 987 # -1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=6bp;gc_cont=0.708	BGC0000085.1|Lankamycin_1 	1	987	-	Loose	1200	52.7582	arnA	24.71	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GTGCGTTTGCTCGTCACCGGCGCCGCCGGATTCATCGGGTCGACCTATGTGCGCAACGTGCTCGCCGGAGCCTACGGCGAGGCCGGCGAAGTGCGGATCACGGCACTGGACAAGCTCACCTACGCGGGCAATCCCGCCAACCTCGCCGAGGTGCGGGGCCACCCGGACCTGACCTTCGTGCAGGGCGACATCTGCGACACGGAGCTGCTCGCCGACCTCGTGCCGGGGCACGACGCGGTGGTCAACTTCGCCGCGGAGAGCCATGTGGACCGCTCGATCGCAGGTGCGGACGACTTCGTGCGCACCAACGTCCTCGGCACCCAGGCCCTGCTGTCCGCGGCGCGTGCCGCGCGGGTGCCCCGGTTCGTGCACATCTCCACCGACGAGGTGTACGGATCGATCGAGTCGGGCTCCTGGACCGAGGACTGCGCCCTGCTGGCGAACTCGCCCTACGCCGCCTCCAAGGCCGGGGCCGACATCCTGGCGCGCGCCTACGCCCGTACGTACGGGATGGACGTGAGCGTGACCCGGTGCAGCAACAACTACGGCCCCCGCCAGTACCCCGAGAAGCTCATCCCGCTGTTCGTGACCAACCTGCTGGAGGGCGAGCGGGTGCCGCTGTACGGGGACGGCCTGAACGTCCGGGACTGGCTGCACGTGGACGACCACTGCCGGGGTGTGCAGCTGGTGCTGGAGAAGGGCAGGGCGGGTCAGGCGTACAACATCGGCGGCGGCGAGGAGCTGACCAACCTCGAACTGACCCGCCTGCTGCTGGCGGAGTGCGGGGCCGATCCGGAGCGGATCGTCCACGTGCCCGACCGGCCGGGCCACGACCGCCGCTACTGCGTCGACGACAGCAGGATCCGGGAGCTGGGGTACGCCCCGCGCGTCCCCTTCCGGGACGGCCTGGCCCACACGGTCGAGTGGTACCGCGACAACCCGCAGTGGTGGAAGCCGCTGCGCCGTACGCCGGCGGTCGCGGTCTGA	MRLLVTGAAGFIGSTYVRNVLAGAYGEAGEVRITALDKLTYAGNPANLAEVRGHPDLTFVQGDICDTELLADLVPGHDAVVNFAAESHVDRSIAGADDFVRTNVLGTQALLSAARAARVPRFVHISTDEVYGSIESGSWTEDCALLANSPYAASKAGADILARAYARTYGMDVSVTRCSNNYGPRQYPEKLIPLFVTNLLEGERVPLYGDGLNVRDWLHVDDHCRGVQLVLEKGRAGQAYNIGGGEELTNLELTRLLLAECGADPERIVHVPDRPGHDRRYCVDDSRIRELGYAPRVPFRDGLAHTVEWYRDNPQWWKPLRRTPAVAV	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	49.55	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1950	polymyxin B
BGC0000085.1|Lankamycin_2 # 1001 # 1792 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=3bp;gc_cont=0.774	BGC0000085.1|Lankamycin_2 	1001	1792	-	Loose	600	26.5646	Burkholderia pseudomallei Omp38	42.86	3004123	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	reduced permeability to antibiotic	General Bacterial Porin with reduced permeability to beta-lactams	ATGAACGACGCCGACGCCGCGGCCGGGACCTGGCTGCGGCGGTTCGGGCCGCCGGGCGAAGGGGCGATGCGGCTCGTCTGCTTCCCGCACGCCGGGGGCGCCGCGAGCAGCTACCGCTCCCTCGCCCGCGCCCTGGGCCCGGAGGCCGAGGTCCTGGCCGTGCAGTATCCGGGCCGGCAGGACCGGCGGCACGAGCCGCCGGTGCCCCGGCTGGACGAACTGGCGGACCGGATCACCGGGGTGCTGGCCGCGCTCGACACGCCGGACGCGGCGCCGTACGCCCTGTTCGGCCACAGTCTGGGGGCGCTCGTCGCCTACGAGACGGCCCGGCGCCTGGACCGCCGCGGCAGCACCCCGCACCGGCTGTTCGTGTCCGCGCGCTGCGCGCCGACGGCCGGGCCGGGGCCGACCGACGGCCTGGACGGCGATGCCGCCCTGCTGGCCGAGGTCCGCAGGCTCGGCGGCGGCGACGCGCTCGACGACCCCGAGGTGCAGGCCCTGGCGCTGCCCGCGCTGCGCGCCGACTACGCGGCCCTGAAGTCCTACACCTGGCGGGAGGGGCCCGCGCTGCGGTGCCCGGTCACGGTGCTCACCGGCACGGACGACCCCCTGTGCACCCCCGAGCAGGCGCTCGGCTGGCTCCGGCTGGCGGTCGTACCGGGGCGCTCACGGGTCTTCGGCGGGGGCCACTTCTATCTGGAGGACCGTGCCACCGAGGTGGCGTCGGCCGTTCTGACCGATCTCGGACTGCGTGCGCCGCAAGCCGCCCTGTCCCGTGCGACCGACACTTGA	MNDADAAAGTWLRRFGPPGEGAMRLVCFPHAGGAASSYRSLARALGPEAEVLAVQYPGRQDRRHEPPVPRLDELADRITGVLAALDTPDAAPYALFGHSLGALVAYETARRLDRRGSTPHRLFVSARCAPTAGPGPTDGLDGDAALLAEVRRLGGGDALDDPEVQALALPALRADYAALKSYTWREGPALRCPVTVLTGTDDPLCTPEQALGWLRLAVVPGRSRVFGGGHFYLEDRATEVASAVLTDLGLRAPQAALSRATDT	MNKTLIVAAVAASFATVAHAQSSVTLYGVLDAGITYQSNVATPSGSGKSLWSVGAGVDQSRFGLRGSEDLGGGLKAIFTLESGFNIGNGRFNNGGGMFNRQAFVGLSSNYGTVTLGRQYDATQDYLSPLSATGTWGGTYFAHPLNNDRLNTNGDVAVNNTVKFTSANYAGLQFGGTYSFSNNSQFANNRAYSAGASYQFQGLKVGAAYSQANNAGANTTGATDPLTGFNIGGTNAASIQGRSRVYGAGASYAYGPLQGGLLWTQSRLDNLANGAPTIRADNYEANVKYNLTPALGLGVAYTYTNAKANGESTHWNQVGVQADYALSKRTDVYAQAVYQRSSKNANASIYNGDLSTPFSTSINQTAATVGLRHRF	70.32	gnl|BL_ORD_ID|2402|hsp_num:0	2786			654	753	cefoxitin; ceftazidime; imipenem; benzylpenicillin
BGC0000085.1|Lankamycin_3 # 1789 # 3009 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=8bp;gc_cont=0.712	BGC0000085.1|Lankamycin_3 	1789	3009	-	Loose	875	28.4906	tet(O/M/O)	22.02	3007120	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGACGACTGACGCGCACACCGCTGTCCCCAGCCTGGACAGCGATCTCTTCCACATCGACCAGTACGAGGCCTACGCCGCGCTGCGCGAGCGCGAACCGGTGAGCAAGGTGAGCTTCATCGGCCGGGAGGCCTTCCTGATCACCCGGCACGCCGAGGCCAAGGCCGCCCTGGGCGACCTGCGGCTCAGCAACGATTTCAAGAAGCAGCCGCCCGGCGTGGAACTGCCCACCTACCACGGGATTCCCGAGGACGTCCGGCCGTACTTCGCCAACAACATGGGCAGCAACGACCCGCCGGCCCACACCCGGCTGCGGCGGCTGGTCTCACGGGAGTTCACCGCACGCCGGGTGGAGTCCATGCGCACGCGGGTCGCGCAGCTCGCCGAGCACCTGCTCGACGGCCTCGCCGGCGAGCGGGAGACCGACCTGGTCGAGCGCTTCGCCTACCCGCTGCCCATCACCGTGATCAGCGAGCTGCTCGGCGTCGAGGAGCGCTACCAGGGCGATTTCGGCCGGTGGAGCAACGAGTTCCTGGTGATCGACGCCGACCGGGTGGAGCAGCGCGAGCACGCCGCCCGCGCCCTGGTCGGCTTCATCCTCGAACTCGTCGACCGCCGCCGCGCCGACCCCGGCTCCGACCTGCTCTCGGCGCTCATCCACGTCCACGACGAGGACGAGGACCGGCTCAGCACCGACGAACTCGCCTCGGTGGTGCTGATCCTGCTCATCGCCGGCTTCGAGACCTCGGTGAGCCTCATCGCCATGGCCACCTACCTGCTCCTCACCCACCCCGGCGAACTGGCCAAGGTCCGCGCGGACCCGTCGCTCGTCCCGAACGCCGTGGACGAGGTGCTGCGCTTCCTCGGCCCCGCCGAGATCACCACCCGCGGAACGCTCGAACCCGTCGAGATCGGCGGTGTGCACATCCCCGCGCACAGCACCGTGCTCATCGCGGGCGCCGCGGCCAACCGCGACCCCCGCCGGTTCCCCGACCCCGAGCGGTTCGACGTCACCCGCGACACCGGCGGACACCTCTCCTTCGGCCACGGCATCCACTTCTGCGTGGGCGGCCCGCTGGCCCGGCTGGAGGGCGAGATCGCGCTGCGCGCCCTGCTGAACCGCTTCCCCGGCCTGGACCTCGCGATCCCGGCGGAGCAGGTGCGCTGGCGCCGGTCCTTCCTGCGCGGCATCGAGAGCCTTCCCGTGAGGCTGGGGCGATGA	MTTDAHTAVPSLDSDLFHIDQYEAYAALREREPVSKVSFIGREAFLITRHAEAKAALGDLRLSNDFKKQPPGVELPTYHGIPEDVRPYFANNMGSNDPPAHTRLRRLVSREFTARRVESMRTRVAQLAEHLLDGLAGERETDLVERFAYPLPITVISELLGVEERYQGDFGRWSNEFLVIDADRVEQREHAARALVGFILELVDRRRADPGSDLLSALIHVHDEDEDRLSTDELASVVLILLIAGFETSVSLIAMATYLLLTHPGELAKVRADPSLVPNAVDEVLRFLGPAEITTRGTLEPVEIGGVHIPAHSTVLIAGAAANRDPRRFPDPERFDVTRDTGGHLSFGHGIHFCVGGPLARLEGEIALRALLNRFPGLDLAIPAEQVRWRRSFLRGIESLPVRLGR	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPMLQTTVEPSKPQQREMLLDALLEISDSDPLLQYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTCFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	63.54	gnl|BL_ORD_ID|4794|hsp_num:0	5790			630	1116	tetracycline
BGC0000085.1|Lankamycin_5 # 4293 # 5105 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=9bp;gc_cont=0.705	BGC0000085.1|Lankamycin_5 	4293	5105	-	Loose	400	37.7354	ErmB	20.24	3000375	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACTTCCGGAGCACAGGCACCCGAGGACCGGGTCGAGGACAAGGTCGTCGATTTCTACGACAACTTCACCGAGGTCTTCAGGGAGATCTGGGGCGACAACCTGCACGTCGGCTACTGGCACGACGACGCCGACGACGCCCCCATCGAGAAGGCCACCGACCAGCTCACCGACCAGCTGATCGCACGGCTGGCGCCCGCGCCGGGCCAGCGGATCCTGGACGTGGGCTGCGGCGTCGGCGAGCCGGCCTTCCGGCTCGCCCGCACGGCCGACGTCGAGGTCGTCGGCGTCTCCATCAGCGCCTACCAGGTCGGCCGCGCCGGCGAGCGGGCGCGCGACTTCGGCCTGGCCGACCGGGTGAGCTTCCGGCACGCCGACGCCGCCGAACTCCCCTTCCCCGACGCGTCGTTCGACGGCGGCTGGGCCTTCGAGTCGCTGATCCACATGCCGGACAAGGAAAAGGTGCTGCGCGAGATCAAGCGCGTCCTGCGGCCGGGCGCCACCCTGGTCCTCGCCGACATGTTCAGCCAGCCCGACACCGAGCTGACCTTCCAGGACATCATCACCACCCCGGAGATGGCCGACTACCGCGCCGTCATCGAAAGCGCCGGACTCGTCGTGCGCGAGTTCACCGACATCACCGCCCACACCCTGGCCCCGCCGGCGGTGCGGGAGAGCGTGGCCGCCGACCTGCTGGCGCGCAAGGACGACGTCATCGCCATGACCGGCCCCGAGGAGTTCGCGCGGATGGTGGACGGCGTGCGGGTCCCCAAGGCCTACGGCTACCTCCTCGCCACGGTCACCACCGACTGA	MTSGAQAPEDRVEDKVVDFYDNFTEVFREIWGDNLHVGYWHDDADDAPIEKATDQLTDQLIARLAPAPGQRILDVGCGVGEPAFRLARTADVEVVGVSISAYQVGRAGERARDFGLADRVSFRHADAAELPFPDASFDGGWAFESLIHMPDKEKVLREIKRVLRPGATLVLADMFSQPDTELTFQDIITTPEMADYRAVIESAGLVVREFTDITAHTLAPPAVRESVAADLLARKDDVIAMTGPEEFARMVDGVRVPKAYGYLLATVTTD	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYNLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRKLIL	108.87	gnl|BL_ORD_ID|1424|hsp_num:0	1549			36	276	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000085.1|Lankamycin_7 # 6210 # 8651 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=9bp;gc_cont=0.715	BGC0000085.1|Lankamycin_7 	6210	8651	-	Loose	500	26.9498	APH(6)-Ia	41.03	3002657	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGAAACGACGAATATGGGTGCCCTCCGTATTTCTGACGGTGCTGGCGCTGCTCAATCTGGGTTCCGCACCGGCGTCCTCCGGTACCGGGGAAAGCCGCGTCGATCGTCTCGTCGACCAGATGACGCTGGACGAGAAGCTCTCGTTCGTGCACTGGGACTACTCCACGACGGACCCCACGGCCCTCGTCTACCTGCCGGGCGTACCCCGCCTGGACATCCCGGAGGTGCGCGCCAGTGACGGGCCCGCGGGCGTCACGATCCACCGCCCGTCGCTGGCGATGCCCGCGCCCGTCAGCCTCGCCTCGTCCTTCGACGACGGCCTCGCCGAGAAGTACGGGCAGGTACTGGGCCGCGAGGGCCGCGCGTTCGGCATGGACGTCCTGTTCGCCCCGATGGTCAACGACATCCGGGTGCCGCAGGCCGGGCGGAACTTCGAGACGTTCAGCGAGGACCCGCTCCTCACCGGGCGCACGGCGGCCGCCGAGGTCACCGGCATCCAGAGCCAGGGCCTGATGGCGACGGTCAAGCACTACGCCGCCAACACCCAGGAGAACAACCGCATGGGCGTGGACGTCGAGGTGGACGACCGCACGCTGCACGAGACGGAACTCCCCGGCTTCGAGGCCGCCGTCGGCGCCGGGGCCGCCGCGGTGATGTGCGCCTACCCCCGCGTCGACGGCGAACCCGCCTGCGGCAGCGACACGTTGCTGACCGGCATCCTCCGCGAGCAGCTGCACTTCCAGGGCTTCGTCACCTCCGACTGGCTGGCCACGCACAGCACCGACGCCATCACCAAGGGACTCGACCAGGAACTCGGCATCGACTCGACCACCGCCATACCGCCCGGCGGGCAGGTCCCCGGCGGCAAGTACTTCGGCGACACCCTGAAGAAGGCCATCACGGACGGAACCATCCCCGTGTCGGTCCTCGACCGGTCGGTGCGCCGCATCCTCGGCCAGATGGACCGCTTCGGCCTGCTGGCCGAGAACAAGCCGCCGCGGCCCCAGCGCGACCTCGCGGGCGGCACCCGCGTGGCCAGGCAGGTCGCCGAGTCCGGCGCGGTGCTGCTGCGCAACCAGGACCGCATGCTGCCGCTGGACGCCGCCGCCACGGACCACCTCGCGGTGATCGGACCGACGGCCAAGACCCCCAAGGTGACGGGCCTCGGCAGCTCCTACATCGTCCCCGACACGGCCACCGCCCCACTGGACGCCATCACCGCGAAGCTGGGCCGGGGCGCGCAGGTCTCCTACGCCGAGGGCGAGGACGTCGAGGGCGAGCCGATCCCGGCCGCCGCCTTCGAACCGCCGTTCTCCGGCGGCACGGTCCTGCAACCGGCCCGCAGCGGCGTCGTCTACGACGGCAGGCTGACCGTGGACAAGGCGGGCCTCTACCGCATCGCGGCCCGCGTGACCGGCGGCAACGGCTCCCTCCAGATCGACGGCGGCGACCCCGTCAGCTTCGGCGAGGTGTTCGGCAAGCTCACCAGCGTCCCGCTGCGGCTGAGCGCCGGCACGCACACCGTCAAGATCAGCGGCGGGGCGCTCGTCGACCAGCCGATGAGGCTGGACCTGAGCTGGGTGACCCCGGCCAGGGCACAGGAGGCGATCGACCAGGCAGTGGAGACTGCCCGCAAGGCCACCACCGCGGTGGTCTTCGCCTACGACGACGGCGCCGAGGGCAGCGACCGCACCTCCCTGTCCCTGCCCGGCTACCAGGACGAGCTGATCAAGGCCGTCACGGCCGCCAACCCCCGTACGGTCGTCGTCCTGAACACCGGCTCGTCCGTCACCATGCCCTGGCTCGACAAGACCCGTGCCGTGCTCGACATGTGGTACCCCGGCCAGGCCGGCGCGGAGGCCACCGCCGACCTGCTGTTCGGCGACGCCGAACCGGGCGGCCGGCTCAGCCAGACCTTCCCCGCCTCCGACCAGGCCACCCCCGTCGCCGGCGACCACGCACGCTATCCCGGCGTGGACGGCGTCGTGCACTACTCCGAAGGCATCTACAGCGGATACCGCTGGTACGACCACGAGGGCGTCAAGCCTCTCTTCCCGTTCGGCTTCGGCCTGTCCTACACGTCCTTCGCGTACGAGGACGAGTCCGTCACCCGCACGGCGGACGGACTCGACGTCGACGTGACCGTGCGCAACACCGGCGACAGGCCGGGCAGCGACGTCGTGCAGGTCTACCTCGGGCCCAGCCCGCGCCTCGCGCTCGACCAGGCCGACAAGGCCCTGGCCGGCTACCGGAAGGTGGCACTGGACCCCGGCGAGTCCCGGCGCGTGCGCATCCACGTGGCCGAACGCGCCCTCCAGTACTGGGACACCTCGGGCGGCGCCTGGAAACTCGCGGGCGGCGAGCGCCGCGTCCTCGTCGGCTCCTCCTCGGACCGGATCCGGCTGACCGCGACCGCGCAGACCGACCGGCCCGGCCGGTAG	MKRRIWVPSVFLTVLALLNLGSAPASSGTGESRVDRLVDQMTLDEKLSFVHWDYSTTDPTALVYLPGVPRLDIPEVRASDGPAGVTIHRPSLAMPAPVSLASSFDDGLAEKYGQVLGREGRAFGMDVLFAPMVNDIRVPQAGRNFETFSEDPLLTGRTAAAEVTGIQSQGLMATVKHYAANTQENNRMGVDVEVDDRTLHETELPGFEAAVGAGAAAVMCAYPRVDGEPACGSDTLLTGILREQLHFQGFVTSDWLATHSTDAITKGLDQELGIDSTTAIPPGGQVPGGKYFGDTLKKAITDGTIPVSVLDRSVRRILGQMDRFGLLAENKPPRPQRDLAGGTRVARQVAESGAVLLRNQDRMLPLDAAATDHLAVIGPTAKTPKVTGLGSSYIVPDTATAPLDAITAKLGRGAQVSYAEGEDVEGEPIPAAAFEPPFSGGTVLQPARSGVVYDGRLTVDKAGLYRIAARVTGGNGSLQIDGGDPVSFGEVFGKLTSVPLRLSAGTHTVKISGGALVDQPMRLDLSWVTPARAQEAIDQAVETARKATTAVVFAYDDGAEGSDRTSLSLPGYQDELIKAVTAANPRTVVVLNTGSSVTMPWLDKTRAVLDMWYPGQAGAEATADLLFGDAEPGGRLSQTFPASDQATPVAGDHARYPGVDGVVHYSEGIYSGYRWYDHEGVKPLFPFGFGLSYTSFAYEDESVTRTADGLDVDVTVRNTGDRPGSDVVQVYLGPSPRLALDQADKALAGYRKVALDPGESRRVRIHVAERALQYWDTSGGAWKLAGGERRVLVGSSSDRIRLTATAQTDRPGR	MSSSDHIHVPDGLAESYSRSGGEEGRAWIAGLPALVARCVDRWELKRDGGVRSGEASLVVPVLRADGTRAALKLQMPREETTAALIGLRAWGGDGMVRLLDHDEESSTMLLERLDGSRTLASVEDDDEAMGVLAGLLNRLHSVPAPPGLRGLGEIAGAMVEEVPSAVDSLADPEDRSRLRGWASAVAELVGEPGDRVLHWDLHYENVLAAEREPWLAIDPEPLVGDPGFDLWPALDTGWERIEATGDARRVVRRRFDLLTESLELDRGRAAGWTLARLLQNTLWDIEDGLTAIAPSQIAVAEALAKP	264.82	gnl|BL_ORD_ID|1382|hsp_num:0	1500			30	147	streptomycin
BGC0000085.1|Lankamycin_8 # 8817 # 10124 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GGGG;rbs_spacer=9bp;gc_cont=0.712	BGC0000085.1|Lankamycin_8 	8817	10124	-	Loose	700	55.8398	oleI	30.08	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	GTGCCCGGTCGAGATCTAAGGACTGTCCAGATGCGCATCGTCTTCTCCGCCATGACGAGCAAGACCCACTTCTACCCGCTCGTCCCGCTCGCCTGGGCCTGCCGCGCGGCCGGCCACGAGGTGCGGGTCGTCGGCTCACCGGGGCTGACGGACATCACCACCGCCGCCGGTCTGACCGCGGTGCCCGTGGGCGAGGACGTCGACCTCGTCGGGCACATGAGCGCCGTCGGCGAGGACATGATCAAGTACGTGCGGTCGCTGGACTTCACCGACGCGGGACTCCAGAACGCGGGCTGGAACCACGTGCTGGGCATGCAGACCGCCCTCACCCCCAACCTCTACGGGCTGATGACCCCTGACTCGCTGATCGACGGGATGGTCGACTTCTGCCGTTCCTGGCAGCCAGACCTGCTGATCTGGGAGCCGCTGACCTTCGCCGCCCCGATCGCGGCCAGGGTGACCGGAGCGGCCCACGCCCGGCTGCTGTGGGGCCCGGACGTCGTCACCAAGTCCCGCCGGGCCTTCCTGGACCTGCGGGACCGGCAGGAGCCGGAGCACCGGGAGGACCCCTTCGCGGAGTGGGTCGAATGGCACCTGGACCGCCACGGGGTGGCGACCGGTCGGGGCTTCGACGAGGAGCTGGCCACCGGCCAGTGGACCATCGACCCGGTGCCGGCGAGCATGCGCCTGGACCTGGGCCTGCCGACCGTGGGGATGCGCTACGTCGACTACAACGGCCCCTCCGTCGTACCGGAGTGGCTGCACGAGCCGCCCGCCCGTCGCCGGGTGGCCCTCACCCTGGGCGTCTCGGGACGCGACAGCGGGGTGGAGGTCATCACCACCGACCAGATCCTGGACGCCGTCGCCGGCATCGACGCCGAGTTCGTCGCCACGCTCGACGCCCACCAGCTCGAATCGGTGGCGCACGTCCCGGACAACGTCCGCGCGGTCGACTTCGTCCCCATGCACGCCCTGCTGCCCACCTGCGACGCGGTCGTCCACCACGGCGGGCCGGGCACCTGGCACACCGCGGCGATCCACGGCGTGCCGCAGGTCATGATGCCCGTCGGCTGGGACACCGACCTGCGGGCCCGCGGGACGGTGGACAGCGGCATGGGCCTCGCGGTGCCGCTCGCGGAACTGACGGCCGACCGGTTCCGGGAAAGCGTCGTCCGTGTTCTGGAAGAGGCGGAATTCCGCGAGGGCGCGGCGAAAGTAAGGGACGAGATTCTGTCCGAGCCGGCGCCTACCGAAGTCGTCGCGGTCCTGGAGAAGATGACCGCCGAACGGCGCCTGCCCCGCCCCTGA	MPGRDLRTVQMRIVFSAMTSKTHFYPLVPLAWACRAAGHEVRVVGSPGLTDITTAAGLTAVPVGEDVDLVGHMSAVGEDMIKYVRSLDFTDAGLQNAGWNHVLGMQTALTPNLYGLMTPDSLIDGMVDFCRSWQPDLLIWEPLTFAAPIAARVTGAAHARLLWGPDVVTKSRRAFLDLRDRQEPEHREDPFAEWVEWHLDRHGVATGRGFDEELATGQWTIDPVPASMRLDLGLPTVGMRYVDYNGPSVVPEWLHEPPARRRVALTLGVSGRDSGVEVITTDQILDAVAGIDAEFVATLDAHQLESVAHVPDNVRAVDFVPMHALLPTCDAVVHHGGPGTWHTAAIHGVPQVMMPVGWDTDLRARGTVDSGMGLAVPLAELTADRFRESVVRVLEEAEFREGAAKVRDEILSEPAPTEVVAVLEKMTAERRLPRP	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	102.59	gnl|BL_ORD_ID|1684|hsp_num:0	1824			897	1266	oleandomycin
BGC0000085.1|Lankamycin_9 # 10106 # 11191 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=8bp;gc_cont=0.784	BGC0000085.1|Lankamycin_9 	10106	11191	-	Loose	1900	25.7942	acrD	37.25	3000491	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCACCACCGACCGACGCCGGCTCGGCAGCCGGCTCCAGATGGCCCGCGGCTGGTACTGGCCGTTCGGCGTGAACGGCGACCCGTACGCGATGCTCCTGTGCGGGCAGGATGACGAACCGGGCCACTGGTACGAGCGGATCCGCACGGCCGGCGCGGGGATCTTCCGCAGCCGCTGCGGGGCCTTCGTCGTGACCCGCTATGACGCCGCCGCCCGGATACTCGACGGCCCGGAGTTCAGCCGGGCCGCGGGGGAGACGGCCCCGGACTGGGCCCGGCCGTTCCTGGACCTGCGCACGGCCGCCGGCCCGCCGCCGCCCGCCGTGGAGGAGCTGGTCCCGCACTACCGCGCGGCGCTGCCGGGCACCGGCACGCGCTTCGACCTGATGCGGGACTTCGCCCGCGAGGTCCCGGTCCGTGCCGAGGCCGCGCGCCTCGGCGCGGACGGCGCGGACGCGGAAGGCATCGCCGCCCTGCTGCGCTCGGCCGCCACGGCACCGGACGCCCGGCTGACCCCGCAGACGCTGGCCGTGACCGAACAGACGGTGGCCGCGCTCCGGGCGCTGCGCGAACAGGCGGGGGCCGCGGGCCCGCCGGCGGCGGCCGGCTGCGCGATGGCGGCCAACACGGTGTGCAACGCCGTGCTCGCCACGCTGCGCACTCCGGGGCTGGCCGGCCGGCTGGCCGACGACCCGGACCTGGCGGACCGCATCGCGGCCGAGACCCTGCGCACCGCGCCCCCGGCCCACCTCGAAAGCCGCCGCGCCACCGCCGCACAGATCATCCAGGGCACCGCGATCGCGGCGGGCGACGAGGTGGTGGTGGCCGTCGCGGCGGCCAACCGTGACCCGGAGGTGTTCGCCGGGCCCGACCGGTTCGACGTGGACCGCGCGGCCGCGCCGCCGCCCCTGACGTCGGGCCTCGGCTGCCGGGACGGCCTGGACGAGTTCGCCGCCCGGCACGCCGCCGCGGCCCTGCGCGCCCTCGCCGGGACGCTGCCCGGCATGACGCGGACGGGCCCCGTGGTCCACCGCCGCCGTTCGCCCGTCGTGCGGGGCATCAGCCGGTGCCCGGTCGAGATCTAA	MTTTDRRRLGSRLQMARGWYWPFGVNGDPYAMLLCGQDDEPGHWYERIRTAGAGIFRSRCGAFVVTRYDAAARILDGPEFSRAAGETAPDWARPFLDLRTAAGPPPPAVEELVPHYRAALPGTGTRFDLMRDFAREVPVRAEAARLGADGADAEGIAALLRSAATAPDARLTPQTLAVTEQTVAALRALREQAGAAGPPAAAGCAMAANTVCNAVLATLRTPGLAGRLADDPDLADRIAAETLRTAPPAHLESRRATAAQIIQGTAIAAGDEVVVAVAAANRDPEVFAGPDRFDVDRAAAPPPLTSGLGCRDGLDEFAARHAAAALRALAGTLPGMTRTGPVVHRRRSPVVRGISRCPVEI	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	34.81	gnl|BL_ORD_ID|1309|hsp_num:0	1427			1989	2142	
BGC0000085.1|Lankamycin_10 # 11188 # 21075 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.761	BGC0000085.1|Lankamycin_10 	11188	21075	-	Loose	700	30.4166	vanS gene in vanB cluster	27.14	3002932	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGAGCGGGAGCCAGGAGACCAGCGGGACCACCGGGTCCACCGAGACCACCGAGTCCACCGAGGACAAGCTGCGCCGCTATCTGCGGCGGACCGCCGGGGACCTGGAGGCCGTCAGCGCGCGACTGCGGGAGACGGAGTACCGGGCCGGCGAACCGATCGCGGTCGTCGGCATGGGCTGCCGCTTTCCGGGCGGCATCGACGGCCCCGCCGCCCTGTGGGACTTCCTCGTGGCCGACGGCGACGCCGTCTCCCCCGCGCCCGCCGGCCGCGGCTGGGACAGCGCCGCCCTCGACGGCTGCACCGGCGGGTTCCTGCACGACGCCGCCGGTTTCGACGCGGACTTCTTCGGCATATCGCCGCGCGAGGCACTGGCCATGGACCCGCAGCAGCGGCTGCTGCTGGAGGTCGCCTGGGAGGCACTGGAACGCGCCGGCTTCGACCCCGCCGCGCTCGGCGGCACCGCCACCGGCGTCTTCGCCGGGGTCGGCGCCGTCGACTACGGGCCGCGCCCCGACGAAGCGGCACCGGAGGTACTGGGCTACCTCGGCACGGGCACGGCCTCCAGTGTGGCCTCCGGCCGGGTGGCGTACACGCTCGGCCTCGAAGGCCCGGCGCTGACCGTGGACACCGCCTGCTCCTCCTCCCTCACCGCGACCCACCTGGCCATGCAGTCGCTGCGTCGCGGGGAGTGCACGACCGCCCTCGCGGGCGGCGCCACCGTCATGAGCACCGCCGGGGCCTTCACCGAGTTCCGCGCCCAGGGCGGACTGGCGGCGGACGGTCGGTGCAAGCCCTTCGCCGAGGCCGCCGACGGCTTCGCGCTGGCCGAGGGCGTCGGCTTCCTCGTACTCCAGCGGCTGTCCACGGCCCGGCGGGAGGGCCGCCGGGTGCTCGCCGTGCTGCGCGGCAGCGCGGTCAACCAGGACGGTGCCAGCAACGGCCTGACCGCGCCCAACGGTCCCGCCCAGCAGCGGGTCATCCGGCAGGCGCTGGAGGACTCCGGGCTCGGCCCCGCCGACGTCGACTACGTCGAGGCGCACGGCACCGGCACCACGCTCGGCGACCCCATCGAGGCACACGCCCTGCTGGCGGCCTACGGTGCCGGACGGCCCGCGCACGCCCCGCTGTGGATCGGCTCGGTGAAGGCCAACATCGGCCACACCCAGGCGGCCGCCGGCGTCGCGGGGCTCATCAAGACGGTGCTCGCCCTCCAGCACGGCCGGCTGCCCCGCCTCCTCCACTTCGACGCCCCCTCCTCGCGGATCGACTGGGAGAGCGGAGCCGTCGTACCGCTCGCCGAGAGCCGGCCGTGGCCGCGCGGCGGCAGGACACGCCGCGCGGGCGTCTCCTGCTTCGGTATCAGCGGCACCAACGCGCACATCATCGTCGAGGAGGCCCCCAAGCCCGACCCGGAACCCGACCCGGTCCCCGAGGCGCCCGCCGCCGACCGGGAGACGGGCCCCTACCCGATCCTGCTGTCCGGCCGCGGCGAGGAGGCCCTGCGGGCCCAGGCCGAACGGCTCGCCGCCCACCTGGAGCGGCCCGGCGCCGACCCGTTGCCGGACGTCTCCTTCACCCTCGCCACCCGGCGTACCGCCTTCCCGCACCGCGCCGTGGTCGTCGGCGGCCCTGCGGACGTGCCGGCCGCCCTGCGCGCCGTGGCCCGCGAGGAGCCGCACGCGCAGGCGGTCACCGCCACGGCGCGCGCGGGCCGCAGGATCGTGATGGTCTTCCCCGGCCAGGGCTCGCAGTGGGAAGGGATGGCCGCCGGACTGCTGGCCGCCTCACCGGTCTTCGCCCGCTCCGTGCGCGAGTGCGAGCAGGCGCTGGCCCCCTACGTCGACTGGTCGCTGACCGAGGTGCTCGCCGGCGGCGCGCCGCTGGAGCGGGTGGACGTCGTCCAGCCCGCGCTGTTCGCGGTCATGGTGTCGCTGGCGGCGCTGTGGCGGGCCCACGGCGTGGAGCCGGACGCGGTGATCGGCCACTCGCAGGGCGAGATCGCCGCCGCCTGCGTCGCCGGTGCCCTCTCGCTCCAGGACGCCGCGAAGGTGGTCGCGGTGCGCGCCAAGGCGCTGCGATCCCTCGCCGGCAGCGGCGGCATGGTCTCCCTCGCCCGCTCCCCGGAGCAGACCGAGGCACTGCTGGCCCGCTACGGCGGCGCCCTGACGATCGCCTCGGTCAACGGCCCGGACGCGGTCGTGGTGGCCGGTCCCCGCGCGGACCTGGACGCGCTGCTGGACGCCTGCGCGGCCGACGGCGTCCGGGCCCGGAACATCCCGGTGGACTACGCCTCCCACTCGCCCATGGTCGAGCCGCTGCGCGCGGAGCTGACGGCCGCGCTGTCCGGCGTGGTCGCCCGCACGGCCCCCGTACCGCTGTACTCCACGACGACCGGCGCGCCGATCGACACCGCCCTCATGGACGGCGACTACTGGTACCGGAACCTGCGGGAGACGGTGCGGTTCGAGACGGGGACGCGGCTGCTGGCCGAGGCGGGCTTCGACACCTTCGTCGAGGTGAGCCCCCAGCCCGTCCTCGCCGCGGGGATCGAGGCGACCCTGGAGGCGGCGGGCGCCGACGCCGCCGTCCTGAGCACACTGCGGCGCGGCGCGGGCGGCCCGGACCGGTTCCTGACGGCGCTCGGCGAGGCCCATGTGCGCGGCGTCCAGGTCGACTGGAGCCCCGCGCTTTCGGCCGGCGCCGTGACCGAACTGCCCTGCTACCCCTTCCAGCACCGCCCGTTCTGGCACACCGCCCCCGGCCGCCGCGCCGAACCCGCCGGCCGGGAACGGCGCTACCGGGTGCGGTGGCACGACGCCGGGTGGGCGGCGGCCCCGCTCACCGGCCGCGTCCTGCTGGTGACCGGCCGCCGGGTGCCGGACGCCTGGTACGACACGGTCCGCGCGGCCCTCCAGGACGCCGGGGCCACGGTCGGCACCGTCGACTGCGACGCACCGGAGCGTGCCGCGACGGCGGCGGCCCTGCGCGCGGCCACGGCCGCCGGGGAACCGGCGGCGGTGGTCTCGTTGCTCGCCCTGGACATCGCAGGGGAATCCGCCGACGACACCGCCGGGGACTCCGCCGCCGCGCCGCACCTGCCCGCCTGGCGGACCCTGAGCCTGATGCAGGCGCTGGGCGACGCGGGTGTCGAGGCGCCGCTGTGGGTGCTGACCCGGCGCGCGGTGGCCGTGACCGAGCAGGACGGGGAGCCGGACCCCGCGCAGACGGCGGTGGCCGGCCTCGGCCGGGCCGCCGGCCTGGAACACCCCGCGCGCTGGGGCGGGTCGATCGACCTGCCCGCCCCGGACCGGGACCTGCTCGCGCGGCTGCCGTGGGTGCTCGCCGATCCCCGCGACGAGGACCAGGTGGCCCTCCGCGCGAGCGGCGACAGGGTCCCCCGGCTCGTGCCCGCCCCGGCGGACGCCCCGGCCGGTGCGGACGGCTGGCGGCCCGGCGGCACCGCCCTGGTGACCGGCGGCACCGGCGGACTCGGTGCCCATGTCGCACGCCGTCTGGCCCGCGCCGGCGCCACCCGTCTCGTCCTCACCAGCAGGCAGGGCCCGAACGCGCCGGGCGCCGAGTCGCTCAGGGCGGAACTGACCGCGCTGGGCGCCCAAGTGACCCTCGCGGCCTGCGACGTCACGGACCGGGCGGCGCTGGCCGCGCTGATCGACGCCGAGCGCGCGCACGGCCGGGCGATCGACGCCGTCTTCCACACGGCCGGCGTGCCGCAGTCCACGCCGCTGGAAGCCATCACCGAGGAGGAGTTCACCCGCGTCACCGCCGCCAAGATCACCGGGACGGCGCACCTCGACGAACTGTGCCCCGACGCGGACACGTTCGTGCTGTTCTCGTCCAACGCGGGCGTGTGGGGCGCGTCCCGCGCCGGCGCCTACGCGGCGGCCAACGCCTTCCTGGACGGCTTCGCACACCGGCGCCGCCGCCGCGGGCTGCCCGCGCTGTCCGTCGCCTGGGGGCTGTGGGACGGACCGGGCATGGCCGGCGACGCGGGCCAGGACTTCCTGCGCCGCCAGGGCATGCGGCCCCTGCCGCCCGAGCAGGCCCTCGCCGAGCTGGGCACGTGCCTGGCGGGCGCCGAAACCTGTGTCTCCGTGGCCGACCTCGACCGGCGCGCGTTCCTCGACCTCATGGGCGCGGTCCGGCACCGGCCGCTGTTCGACGAACTCGCCCGTACGCTGCCCGCCGCGCCGTCGGCCGGAGAGCCGCGGGAGGAACCGGAGGGCCGCTCCCGGCTGCGCGACAAGCTCCTGCCGCTGCCGGCCGGGGAGCGCCGCGAACACCTGCTGCGCCTGGTGCGGGCCGAGGCCGCCGCGGTGCTCGGGCACGCCGACGCCGGGGCCGTCGACCGGGACCGCGCCTTCCGGGAACTCGGCTTCGACTCGATGTCGGCGGTGCAGCTGCGCAACCGCATCACCGCGGCGACCGGCCTGCGCGAGGCGACCACCCTGGTCTTCGACCGGCCCAGTGTCACCGCGCTCGCCGACTATCTCCTCGACCGGCTGTTCGGCTCCGAGGAGATCCCGGCGGACGGGGCGGAGTCCGCGGCGGGGCCCGCCGGACCCGCCGCACAGGCGTCCGGCGGGTCCGGCGGGGACGGCGGGGACGACCCGGTGGTGATCGTGGGCATGGCCTGCCGGCTGCCCGGTGGCATCGGTTCCCCGGAGGACCTGTGGGAGTTCGTCGCCGCCGGCCGTGACGCCGTCGCGCCGATGCCCGCCGACCGGGGCTGGGACCTCGACCTCCTCGGCGCCACCACCGCCGACGGCGCGAGCGGACCCCGCCACGGCGCCTTCCTCGACGACGCGGCGGGCTTCGACGCGGCGTTCTTCGGGATCTCCCCGCGTGAGGCGCTGGCGATGGACCCGCAGCAGCGCCAGGTGCTGGAGGCCACCTGGGAGGCGATGGAGAACTCCGGCATCGATCCGCGCGCGCTGCGCGGCAGCGACACCGGCGTCTTCCTCGGCGCCGCCTACCAGGGCTACGGCCACGGGGCCGAGACCCCCGAGAGCAGCGAGGGCTATCTCCTCACCGGTGGTTCGCCCGCCGTCGCCTCCGGCCGGGTGGCGTACGTACTGGGTCTGGAGGGGCCGGCGTTGACGGTGGACACGGCGTGTTCGTCGTCGTTGGTGGCGTTGCATCTGGCGGCGCGGTCGTTGCGGGACGGGGAGTGCTCGCTGGCGGTGGCCGGTGGGGTGTCGGTGATGGCGGGTCCGGAAGTGTTCACGGAGTTCTCGCGGCAGGGGGCGCTGGCGGCGGACGGGCGGTGCAAGGCGTACTCCGACGACGCCGACGGCTTCGGCTTCGCCGAGGGCGTGGCCCTGCTGGTGCTGGAGCGGCTCTCGCAGGCGCGGCAGCGGGGGCACCGGGTGCTCGCCGTGGTCCGGGGCAGCGCGGTCAACCAGGACGGAGCCAGCAACGGGCTCGCGGCGCCGAGCGGCCCCGCGCAGCAGCGGGTGATCCGGCGCGCCTGGCAGGCCGCCGGGATCTCGGGCGCGGACGTCGACGTCGTGGAGGGTCATGGGACGGGGACGGCGCTGGGTGATCCGATCGAGGCGCAGGCGCTGCTGGCGACGTATGGGCAGGGGCGTGATCCGGGTCGGCCGTTGTGGCTGGGGTCGGTGAAGTCGAACATCGGGCATGCGCAGGCGGCGGCGGGTGCGGTGGGTGTGATCAAGATGGTGCTGGCGCTGGGGCGGGGTGTGTTGCCGGGGTCGTTGCATGCGGGGGTGCCGTCGTCGCATGTGGACTGGTCTTCTGGTGGGGTGCGGGTGCTCGGGGAGGCGCGTGCGTGGCCGTCCGGTGGGCGGGTGCGGCGTGCGGGGGTGTCGGCGTTCGGGGTGAGCGGGACGAACGCGCATGTGATCGTGGAGGAGGCGCCGTCGTTGCCGGTGGAGGCCGGTGCTGCGGGCGGGCCGGTGGGGGTGCTGGAGGCGGCGGGTGTGGTGCCGCTGGTGGTGTCGGCGCGTACGGAGACCGCGCTGGCCGCCCAGTCCCGCCGGCTGCTCCCGGTGCTGGACGACGACGCGCCCGACCCGGACACCCTGGACCGCGTCGGCCGCACGCTCGCGACCGGACGCACCCACCACGAGCAGCGCGCCGTCGTCCTCGCCGAGGACACCGGCATGGCCCGAGACCTGCTGCACCGGCTCGCGGAGGGGTTGCCGGCTCCCGGTCTGGTCACGGGTGTGGGTGGTGGGGGTCGTCGTGTGGTGTGGGTGTTTCCCGGTCAGGGGTCGCAGTGGGTGGGGATGGGCCGCGGGCTGCTCGATGTGCCGGTGTTCGCACAGGCGTTGGCGGAGTGTGATGCGGCGCTGGCGGAGGTGGCGGGTTTCTCGGTGGTGGATGTGGTGCGGGGTGTGGAGGGGGCTCCGGGGCTGGACCGGGTGGAGGTGGTGCAGCCGGTGCTGTTCGCGGTGATGGTGTCGCTGGCGCGGTTGTGGCGGGCGTGCGGCGTGGAGCCGGATGCGGTGGTGGGGCATTCGCAGGGCGAGATCGCGGCGGCGTGTGTGGCGGGGGCGCTGTCCTTGCCGGACGCGGCGCGGGTGGTGGCACTGCGGGCCCAGGCCCTGGCCGAACTCGCCGGCCCCGGCGCCATGACCTCCGTCGCGCTGCCCGAGGACCGGGCGCGGGAACTGATCGCCGAGTGGCCGGAGCGCGTGAGCGTCGCCGCCGTCAACTCCCCGGCGTCCGTGGTGGTGGCCGGCGACCCCGAGGCGCTGACCGCGTTCGAGGAGCGCTGCGCCGCCGACGGGATCCGGGCCCGCCGCATCCCCGTCGGCTACGCCTCGCACTCGCCCCACATGGAGCGGCTCCGCCGGCGCGTCCGCACCGACCTGACGGGCGTGACCCCGCGCCCGACCGGGACGCCCCTGTACTCCACGCTGCGCGGCGAACGCTGCGACACCGGCACGATGGACGCCGCGTACTGGTACGACAACCTGCGCTCCCCGGTCCGCTTCGAGGCGGCCGTCCGCGCCGCCGTCGAGGACGGCTACGACACCTTCGTCGAGGTCAGCCCGCACCCCGTGCTCACCACCAGCGTCCAGGAGACCGCCGAGCGCCACGGCAGCGAGGTGCTCGTCCTCGGCAGCCTGCACCGGGACGAGGGCGAGCGGCACTTCGTCCGCGAACTCGCCCGCGCACACGCGGGCGGCGTGTCCGTCGACTGGCGGGCCGTCTTCCCCGACGGCGCGCCCGCCCGGCTGCCCAACTACCCCTTCGAACACGAGCGGTACTGGCTGGCGCCCGAGATCCCCGACCGGGTGTGCGACTGGCGCTGCCGCATCGAATGGCGCCCCCTGTCCCCGGCCACGGACCCGCTGAGCGGCACGTACCTGGTGGTCGGCACCGGCACCGGTCCGCAGGAGGACACCCTGGCCGGTGCCGTGGAGGACGCCGGCGGCACGGTGCTGCGGCTCACGGCCGACGCCGTGGCGACCGGACGCGAGGAGCTGGCGAGGACGCTGCGGGAGGCGGCCCCCGGCGGCGTCACCGCGGTCGTCTCGCTGCTGGCCCTGGCAGCCGACCCGTCCGACCCGTCCGGCCCGAACGACCCGTCCGGCCCGAACGACCCGTCCGGCCCGGACGACGAGCTGCGGGCCGCCACCGCCGCCCTCACCCTGCACCAGGCACTCGGCGACGCGGGCGTCGAGGCGCCCCTGTGGCTGGTGACCCGCGGGGCCGTGGCCGTCGGACAGGACGCGGCGGACGCCACGGCCGACCCGGCGCAGGCCATGGTCTGGGGCATCGGGCGGGTGATGGGCCTGGAGGCCCCCGGACGCTGGGGCGGCCTGCTCGACCTGCCCGGCGAACTCACCCCGTCCGTCCTGCGGTGGTTCACCGCCTGCCTCCAGCAGGCGGGGGACGAGGACCAGCTCGCGCTGCGCGAGGGCGGCTGCTTCGTCCGACGGCTCGTCAGGGCCCCGCTGGAGCCCGTCGCGGCTCCCTGGCAACCGGCCGGCACGGCCCTGGTCACCGGCGGCACCGGCGCCCTCGGCGGTCATGTCGCCCGCCACCTCGCCCGCGCCGGGGCGGACCACCTGGTGCTGGTCGGCCGGTCGGGCGGACCGGCGCCGCAGCACGCGGAACTGGCCGCGGAACTGACCGCCCTGGGCGCCCGCGTGACGTTCGCGGCCTGCGACGTCACCGACCGCGCCCGGCTGACGGAACTGATCGACGGGCTGCGGCGCCAGGGAGAGCCGGTCCGTACCGTGATGCACCTCGCCGGTGTCCCCGACGGACGCGCCCTGACCGACCTCGACCCGGACGAACTGGCGCGGGTGACGCGGGTCAAGACGGTCGGCGCCCGGCTGCTGGACGAACTCTGCCCGGACGCCGAGACGTTCGTCCTCTTCTCCTCCGGCGCGGGGCTCTACGGCAGCGGCCTGCTCGGCGCCTACGCCGCGGGCAACGCCTACCTCGACGCGCTGGCGCACCGGCGCCGGGCCGCGGGCAAGCCCGCGACCAGCATCGCCTGGGGAGCCTGGGCCGACGGCGGCATGGCCGACGCCGACCTGCCCGGTCTGATCCGCCGCGGGATGCGCCCGATGGCCCCCGACAAGGCGGTGCGGGCCCTGCAACAGGCCCTGGACCAGCGGGACGTCTGCGTCTCGATCGCCGACATCGACTGGAACCGGTTCGCCGTCGGCTTCACCGCCGCCCGGCCGCGCCCGCTCATCGAGGACCTGCCCGACGCCGCCCGGCAGGCACCCGCCGAACCCGCCCACGACGGGCCCGGCCGCCGCTCCACCTGGCCGGAACGGCTGTCCGGCCTGCCCGCGGACGAGGCCGAGGCCATGCTCGCCACATGGATCCGCGCACAGGTGGCCACCGTCCTCGGCCACCGGGACCCGGACGCGGTGGGACTGCACCAGCCCTTCGCCCAGCTGGGCTTCGACTCGCTGTCGGCGATGGGGGTGCGCAACAGGCTGCAGGACGCCACCGGCCTGCCGCTGGCCACCACCCTGGTGTTCGACCACCCCAGCGTCACCGATGTCGCCGCCTACCTGCGGCCCCTGCTCACCTCGGAAACGCCGCACCCCGCGGCCGACGGCGGCGGCATGCTGCGCGGCCTCTACGAGCGATCCGTCCAGCAGGGACGCTTCGACTCCTACCTGGAGCTGCTCGGCGAACTGGCGGGCCACCGGGACCACTTCACGGGCCCCGAGGACCTGTCCGCATCCGTCGACCTCGTGGAACTGGCCTCCGGTCCGGGGGAGATCCGGCTGATCTGCGTCGCCGGTACGGCCCCGGTGGCGGGCCCGCACGAGTTCCTCCGGCTGGCCGCCGCCTTCGAGGGCAGCATGCCGGTGTCCGCGCTTCCGCAGCCGGGCTACGAGCCGGGCGAGCAGCTTCCCGCGTCGCTGGCGGCGGTCCTCGGCGTCCAGGCGGACGCCGTCCTGAAGTCCGCGGACGGGCCGTTCGTGCTCGTCGGCCACTCGGCGGGCGCCCTGATGGCGCACGCCCTGGGTGCCGAACTCGCCGACCGCGGCCGTCCGCCGCACGGCATCGTCCTGATCGACGTCTATCCGCCGGGACGGCAGCAGGCGGTGCAGGGCTGGCTCGCCGAACTGACCGACACCATGTTCGGCCGCGAGGGGGTGCGGGTGGACGACACCCGGCTCACCGCCCTGGGCGCGTACCACCGCTTCACCAGCACCTGGCAACCACGGGACCTCGCCGTCCCGACCCTGCTGGTACGGGCCTGCGAGCCGCTCGGAGAGTGGCCGGACGGCACGTCCTGGCAGTCCACCTGGCCGTTCCCGCACACGTGCGTGGACGTGCCCGGCAACCACTTCTCGATGGTGCAGGAGCACGCCGGCGCAGTCGCCGAACGCATCCGCACATGGACAGGGAACGAGGCATGA	MSGSQETSGTTGSTETTESTEDKLRRYLRRTAGDLEAVSARLRETEYRAGEPIAVVGMGCRFPGGIDGPAALWDFLVADGDAVSPAPAGRGWDSAALDGCTGGFLHDAAGFDADFFGISPREALAMDPQQRLLLEVAWEALERAGFDPAALGGTATGVFAGVGAVDYGPRPDEAAPEVLGYLGTGTASSVASGRVAYTLGLEGPALTVDTACSSSLTATHLAMQSLRRGECTTALAGGATVMSTAGAFTEFRAQGGLAADGRCKPFAEAADGFALAEGVGFLVLQRLSTARREGRRVLAVLRGSAVNQDGASNGLTAPNGPAQQRVIRQALEDSGLGPADVDYVEAHGTGTTLGDPIEAHALLAAYGAGRPAHAPLWIGSVKANIGHTQAAAGVAGLIKTVLALQHGRLPRLLHFDAPSSRIDWESGAVVPLAESRPWPRGGRTRRAGVSCFGISGTNAHIIVEEAPKPDPEPDPVPEAPAADRETGPYPILLSGRGEEALRAQAERLAAHLERPGADPLPDVSFTLATRRTAFPHRAVVVGGPADVPAALRAVAREEPHAQAVTATARAGRRIVMVFPGQGSQWEGMAAGLLAASPVFARSVRECEQALAPYVDWSLTEVLAGGAPLERVDVVQPALFAVMVSLAALWRAHGVEPDAVIGHSQGEIAAACVAGALSLQDAAKVVAVRAKALRSLAGSGGMVSLARSPEQTEALLARYGGALTIASVNGPDAVVVAGPRADLDALLDACAADGVRARNIPVDYASHSPMVEPLRAELTAALSGVVARTAPVPLYSTTTGAPIDTALMDGDYWYRNLRETVRFETGTRLLAEAGFDTFVEVSPQPVLAAGIEATLEAAGADAAVLSTLRRGAGGPDRFLTALGEAHVRGVQVDWSPALSAGAVTELPCYPFQHRPFWHTAPGRRAEPAGRERRYRVRWHDAGWAAAPLTGRVLLVTGRRVPDAWYDTVRAALQDAGATVGTVDCDAPERAATAAALRAATAAGEPAAVVSLLALDIAGESADDTAGDSAAAPHLPAWRTLSLMQALGDAGVEAPLWVLTRRAVAVTEQDGEPDPAQTAVAGLGRAAGLEHPARWGGSIDLPAPDRDLLARLPWVLADPRDEDQVALRASGDRVPRLVPAPADAPAGADGWRPGGTALVTGGTGGLGAHVARRLARAGATRLVLTSRQGPNAPGAESLRAELTALGAQVTLAACDVTDRAALAALIDAERAHGRAIDAVFHTAGVPQSTPLEAITEEEFTRVTAAKITGTAHLDELCPDADTFVLFSSNAGVWGASRAGAYAAANAFLDGFAHRRRRRGLPALSVAWGLWDGPGMAGDAGQDFLRRQGMRPLPPEQALAELGTCLAGAETCVSVADLDRRAFLDLMGAVRHRPLFDELARTLPAAPSAGEPREEPEGRSRLRDKLLPLPAGERREHLLRLVRAEAAAVLGHADAGAVDRDRAFRELGFDSMSAVQLRNRITAATGLREATTLVFDRPSVTALADYLLDRLFGSEEIPADGAESAAGPAGPAAQASGGSGGDGGDDPVVIVGMACRLPGGIGSPEDLWEFVAAGRDAVAPMPADRGWDLDLLGATTADGASGPRHGAFLDDAAGFDAAFFGISPREALAMDPQQRQVLEATWEAMENSGIDPRALRGSDTGVFLGAAYQGYGHGAETPESSEGYLLTGGSPAVASGRVAYVLGLEGPALTVDTACSSSLVALHLAARSLRDGECSLAVAGGVSVMAGPEVFTEFSRQGALAADGRCKAYSDDADGFGFAEGVALLVLERLSQARQRGHRVLAVVRGSAVNQDGASNGLAAPSGPAQQRVIRRAWQAAGISGADVDVVEGHGTGTALGDPIEAQALLATYGQGRDPGRPLWLGSVKSNIGHAQAAAGAVGVIKMVLALGRGVLPGSLHAGVPSSHVDWSSGGVRVLGEARAWPSGGRVRRAGVSAFGVSGTNAHVIVEEAPSLPVEAGAAGGPVGVLEAAGVVPLVVSARTETALAAQSRRLLPVLDDDAPDPDTLDRVGRTLATGRTHHEQRAVVLAEDTGMARDLLHRLAEGLPAPGLVTGVGGGGRRVVWVFPGQGSQWVGMGRGLLDVPVFAQALAECDAALAEVAGFSVVDVVRGVEGAPGLDRVEVVQPVLFAVMVSLARLWRACGVEPDAVVGHSQGEIAAACVAGALSLPDAARVVALRAQALAELAGPGAMTSVALPEDRARELIAEWPERVSVAAVNSPASVVVAGDPEALTAFEERCAADGIRARRIPVGYASHSPHMERLRRRVRTDLTGVTPRPTGTPLYSTLRGERCDTGTMDAAYWYDNLRSPVRFEAAVRAAVEDGYDTFVEVSPHPVLTTSVQETAERHGSEVLVLGSLHRDEGERHFVRELARAHAGGVSVDWRAVFPDGAPARLPNYPFEHERYWLAPEIPDRVCDWRCRIEWRPLSPATDPLSGTYLVVGTGTGPQEDTLAGAVEDAGGTVLRLTADAVATGREELARTLREAAPGGVTAVVSLLALAADPSDPSGPNDPSGPNDPSGPDDELRAATAALTLHQALGDAGVEAPLWLVTRGAVAVGQDAADATADPAQAMVWGIGRVMGLEAPGRWGGLLDLPGELTPSVLRWFTACLQQAGDEDQLALREGGCFVRRLVRAPLEPVAAPWQPAGTALVTGGTGALGGHVARHLARAGADHLVLVGRSGGPAPQHAELAAELTALGARVTFAACDVTDRARLTELIDGLRRQGEPVRTVMHLAGVPDGRALTDLDPDELARVTRVKTVGARLLDELCPDAETFVLFSSGAGLYGSGLLGAYAAGNAYLDALAHRRRAAGKPATSIAWGAWADGGMADADLPGLIRRGMRPMAPDKAVRALQQALDQRDVCVSIADIDWNRFAVGFTAARPRPLIEDLPDAARQAPAEPAHDGPGRRSTWPERLSGLPADEAEAMLATWIRAQVATVLGHRDPDAVGLHQPFAQLGFDSLSAMGVRNRLQDATGLPLATTLVFDHPSVTDVAAYLRPLLTSETPHPAADGGGMLRGLYERSVQQGRFDSYLELLGELAGHRDHFTGPEDLSASVDLVELASGPGEIRLICVAGTAPVAGPHEFLRLAAAFEGSMPVSALPQPGYEPGEQLPASLAAVLGVQADAVLKSADGPFVLVGHSAGALMAHALGAELADRGRPPHGIVLIDVYPPGRQQAVQGWLAELTDTMFGREGVRVDDTRLTALGAYHRFTSTWQPRDLAVPTLLVRACEPLGEWPDGTSWQSTWPFPHTCVDVPGNHFSMVQEHAGAVAERIRTWTGNEA	MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRAMEAQQTVKSYQPLVELIQNSDRLDMQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNADTSNSVRPDFLYVVHRDDNISIVAQSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKEVPPPLERKDELGALAHDMHSMYIRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIAAVSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKTISEILELVSLNDGRIVPIAEPLDIGRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPKLIQKALSNVILNAVQNTPQGGEVRIWSEPGAEKYRLSVLNMGVHIDDTALSKLFIPFYRIDQARSRKSGRSGLGLAIVQKTLDAMSLQYALENTSDGVLFWLDLPPTSTL	737.14	gnl|BL_ORD_ID|4672|hsp_num:0	499			762	942	vancomycin
BGC0000085.1|Lankamycin_11 # 21072 # 32042 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.770	BGC0000085.1|Lankamycin_11 	21072	32042	-	Loose	660	70.0922	MexS	29.41	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACGGACAACGACAAGGTCGCTTCATACCTGCGCCGGGCCACCCTGGACCTGCGAGCGGCCCGGCGGCGCATCCACGAGCTGGAGGCCGACCCGGTCGCGATCGTCGGCACGGCCTGCCGGCTGCCCGGCGGGATCGAGACCCCCGAGGCCTTCTGGGAGGTGCTGGCGGCGGGCGAGGAACGGCTGTCCGCCTTCCCCGAGGACCGCGGCTGGGACCTGACCGGCCTCTACCACCCGGACCCCGACCACCCCGGAACCACCTACGTGCGCACCGGCGCGTTCCTGGAGCGCGCGGGCGAATTTGACGCCGCCTTCTTCGGCGTCTCCCCGCGCGAGGCCGCCGCGATGGACCCCCAGCAGCGCCTTCTGCTGGAGACGAGCTGGGAGCTGATCGAGAACGCCGGACTGGACCCGCACAGCCTGCGCGGCACCGACACCGGGGTGTTCCTCGGCGTCGCCCGGCACGGCTACGGCGACACCGGCGGCTCCGCCGAGGACGCCGAGGGCTACACGGTCACCGGCGCGGCGCCCTCCGTCGCCTCCGGCCGGATCGCCTACACCCTCGGTCTCGAAGGCCCCGCCATCACCCTGGACACGGCCTGCTCCTCCTCCCTCGTGGCCCTGCACCTGGCGGTGGCGTCGCTGCGCCGCGGCGAGTGCGGCCTCGCGATCGTGGGCGGCGCCGCGGTGATGGCCGGCCCCGAGGTGTTCGTCGACTTCGCCCGGCAGCGCGCCCTCGCCGCCGACGGCCGATCCAAGGCGTTCGGCGCGGGCGCCGATGGCTTCGGCTTCGGCGAGGGCGTCGCGGTGCTCCTCCTGGAGCGCCTGTCGGACGCCCGGCGCCGCGGGCACACCGTGCTCGCCGTCGTCCGCGGCACCGGCATCAACCAGGACGGCGCCAGCAACGGCCTGGCCGCACCCAGCAGAGCCGCCCAGCGCAAGGTCATCGAACAGGCCCTGGCCAACGCGGGCGTGGCCCCCGGCGATGTCGACGCGGTCGAGGCGCACGGCACCGGCACCACCCTCGGCGACCCCATCGAGGCCCACGCCCTGCTCGACACCTACGGCCGGGGCCGCGGCCCGCAGCGGCCGCTGTGGCTCGGCTCGGCGAAGTCGAACATCGGCCACACCCAGGGCGCCGCCGGCGCGGTCGGCGTGCTCAAGATGGTGCTCGCCCTCCGGCACGAGCGGCTGCCCAGGACCCTCCACGCCGAGGAGGCCTCGCCGCACGTCGACTGGTCCTCGGGCGCGGTCGCGCTGCTCGCCGAGGAGCAGCACTGGCCGCGCGGCGAACGGCCCCGGTACGCCGCCGTGTCGGCGTTCGGCATCAGCGGCACCAACGCCCACGTCGTCCTCCAGGAAGCCCCCGCACCCGAGGAGACCGGCGAACGCGCGGCCCCGCGGCCGGCCACGCCGCAGCACCCGGTGCCGCTGGTCGTCTCGGCCCGCAGCGAGGAGGCCCTGCGCGCCCAGGCACGGCGGCTGTCCGACGTGCTCGCGGACACCGACGCCGAACTGCCCGGCATCGGCCTGACGCTGGCCACCGCACGGGCCCGGCACGAGCACCGCGCGGTGGTCGTGGCCGGCTCCCGCGACCTCGCGCTGCACGGGATGCGCGAGGTGGCCGCCGGTGCGGCACGCCTCACGGGCACCGTCGAATCGGGCGGGCGCTCCGCCGTGTTCCTCTTCCCCGGCCAGGGCTCCCAGTGGGCGGGCATGGGCGCCGACCTGCTGGCCTGGTCCCCGGTGTTCGCCGAGACGATCCGGGCCTGCGACGAGGCGATGGCCCCCTGGCAGGACTGGTCGGTGGCCGCGGTGCTGCGGCAGCAGCCCGGCGCCCCCGGACTCGACCGCGTCGACGTGGTGCAGCCCGCGCTGTTCGCCGTGATGGTGTCCCTGGCCGCGCTGTGGCGCTCCTACGGCGTGGAACCGGCGGCCGTGGCGGGACACTCGCAGGGCGAGATCGCCGCGGCGTACGTCGCCGGGGCGCTGACACTGGAGGACGCCGCCCGGCTCGTGGTGCTGCGCAGCCGCCTGCTGCGATCACTGGCCGGAAAGGGCGCCATGGCGGCCGTGGCGCTGGACGAGGCCGCGGTCCGCGAGCTGCTCGTGCCGTACGCGGGCGCCGTCGAGGTGGCCGCGGTCAACGGGCCCGCCTCCGTCGTCGTCTCCGGCGAACCCGCCGCGGTGGACTCCTTGGTGGCGGACTGCGCCGGCCGCGGAGCGCGCGCCCGGACCATCGACGTGGACTACGCCTCGCACTCCGCGCAGATGGAAGAGGTCCGCGAGGAACTGGCCGCGGCCCTGCGGGACCTGCGCCCCGGCCGCGCGCGGGTCCCGTTCTACTCGACGGTGACCGGCCGCCCGATGGACGGCGGGGAACTGGACGCCGGCTACTGGTACCGCAACCTGCGCGAGCCGGTGCGCCTGCACGACGTCGTACGCCTCCTTGCGGACGCGCACCACGACACCTTCATCGAGGTCAGCCCGCACCCGGTGCTGGCGGCGACGGTCGAGGAGACGCTGGAGGCGGCGGGCCGGGAGCCCGGCGCGGCCCTGGCCCTGGGCACCCTGCGGCGCGGCGCGCCCGGCCCGGAGTCCTTCCTCACCTTCGCGGCGAGCGCCCATGTCGAGGGCGTGGACGTGCGCTGGCAGCCCGCCTTCGGCGACGACGCGCGGCCCGTCGCGCTGCCCACGTACCCGTTCCAGCGCAAGCACTACTGGACGGCCCCCGCCGGGCCCGCCCGCGCCACCGGCGGGGTGACCTACCGCGTGTCGTGGACGCCGCTGCCCGCCCCGGAGCCGGCCGACGCGCGCGGGCCCTGGCTGATCGTCGGCCCGGCCGCGTCCCCGGCCTGGGCCGGCCTGCTGCCGGCCGCGGTCCGCGAGGCCGGCGGCACGCCGCTGGAGTGCGCCCTGGACCCCGGCCTGGACCGCGCCGGGGCCGCCGCCGCGCTCACCGCGGCCCTCGCGGGCACCACCGGTGTGCGGGGCGTGCTCTCGCTGCTCGCGGCCGACGAATCGGACCACCCCGGCCGGCCGGGCGTGCCCGTCGGCGCGGTCGCCACCCTCACGCTCGCGCAGGCCCTCGCCGACGCCGGGGTGGACGCGCCGCTGTGGTGCCTCACCCGCGGCGCCGTGCAGACGGACGAGGACGACGGCATCGGGTCGTACGCGCAGAACGCCGTGCACGGCCTGGGCCGGGTCGCCGGTCTGGAACTCGGGCGGCGCTGGGGCGGCGTGCTGGACCTGCCGCACCCGGACGGGGCCGACGCGGCCCTGCTCGGCCGGGTGCCGGGCCTCCTGGCCGGCGCGCACGCCGCCGAGGACCACCTCGCCCTGCGGCCCGGCGGCCTGTACGGGCGGCGGCTGGTGCCGGTGCGGACCCCAGCCACGACGGACGGCACCGGCCCGCGCCTGCACGGGACCGTACTGCTGACCGGGGCGGACAGCCCGATCGGCGCCCGGCTCGCCCGGTGGGCGGCCGACAGCGGCGCCGACCATCTCCTGCTCGTCGGCGAGGCGGACGAGGAACTGCTGAACGCGCTGCGGGAGCGCGGCACGACGGCCACCCGCTGCGCGGCGGACGAGGACGCCCTGCGGGCCGCCGTCGAAGCCGCCCCGCACGACATCAGCACCGTCGTACACGCCGCGACCCGCACGGAGTTCGGGCCGGTCCTCGCCACCGACCCGGAGGACTTCGCCGCCACCCTCCAGGCCAAGACCGGACTCGCCCTGACCCTCGCCGCGGTCCTCGACGGCCGGCCGGTGGAGCGGGAGATCCACTGCTCGTCGGTGGCCGGCGTCTGGGGCGGTGCCGGCATGGCCGGATACGCGGCCGGCAGTGCCTGCCTCGACGCGTTCGCCGCCCACCGGCGGGCCCAGGGCCACCCGAGCACCGCCGTGGCCTTCAGCCCCTGGGCCCTGCCCGGCACCGTGCCGTCCGCCCCGCAGGCGGCGCAGCGCGGGCTGCGCGGCCTGAGCGCCGACCGCGCCCTCGCGGCCCTCACGTCCGCACTGGACTCGGGCGAGAGCGCCGTCGCGGTGTCCGACGTGGACTGGCCCGCCTTCGCCGCGGGCTTCGGCGCGGTGCGGCCCACCGCGCTGTTCGCGGAGATCTCCGAAGCGCGCGAGACGGCGGAGCCCCCGGCGGCGCCCGCCGCACCGGACGGCTCACCGGCCGCCGACCTGGCCGCCCGGCTCACCGCCCGCACGCCCGCGCAGCGCGAGGAGCTGCTGATCGGCGTGGTCGCCGAGGCCACCGCGGCGGTCCTCGGACACGACAGCGCCGAGGACGTCAGCGCACGGCGGGCGTTCACCGAACTGGGCCTGGACTCGCTGGGCTCGGTGCAGCTGCGCAAGCGGCTCTCCGCGGCCACCGGTCTGCGCCTGCCCGCCTCCCTGGTGTTCGACCACCCGACCGTCACCCGGCTCGCCCGCCATCTGCTGTCCCTGCTGGCCGCCGACTCCGGCCCGGAGCTCGCCGCCGCGGTGGGGAGCGCGCCGCCGAGCGCCGAGGACGAGCCGATCGCCATCGTCGGCATGAGCTGCCGCTTTCCGGGCGGCATCGGCTCGCCCGAGGAGCTGTGGCGGGCCGTCGTCGACGGACAGGACCTCACCGGCGAGCTGCCCCGCGACCGGGGCTGGGAACTGGGGGCCCTGTACCACCCCGACCCCGACCACCCCGGCACCAGCTACTCCGACCGGGGCGGGTTCCTCGCCGACGCGGCGGGCTTCGACGCGGAGTTCTTCGGCATCACCCCCCGCGAGGCGCTCGCGATGGATCCGCAGCAGCGGCTGATGCTCGAAGTCGCCTGGGAGGCCGTCGAGCGGGGCGGTATCGACCCGGACGCGCTGCGCGGCAGCCGCGTCGGCGTGTTCGTCGGGTCCAACGGCCAGTCGTACATGCCGCTCCTGCGCGGCGAGGCCGACCGGGTCGAGGGCTACCAGGGGCTCGGCAACTCGGCGAGCGTGCTCTCGGGGCGCCTCGCCTACACCTTCGGCTGGACGGGGCCGGCCCTCACCGTGGACACGGCGTGCTCGTCCTCCCTGGTGGGCATCCACCTGGCGATACGGGCCCTGCGCGACGGCGAGTGCGCCATGGCGCTGGCCGGCGGGGTCACCGTGATCTGCGACCCCTACACGTTCGTGGACTTCAGCAGACAGCGCGGTCTGGCCGCCGACGGGCGGTGCAAGCCGTTCTCGGCGCAGGCCGACGGCTTCGGTCTCGCCGAGGGGGCCGGCGCCCTGCTCCTCGAACCGCTCTCCCGAGCCATCGAGTCGGGCCACCCGGTGCTCGCCGTGCTGCGGGGCAGTGCGGTCAACCAGGACGGCGCGAGCAACGGACTGGCCGCGCCGAACGGTCCCGCCCAGGAGGAGGTGATCCGGCAGGCGCTCGCCGACGCCCGGCTGTCGGCGGCCGACATCGACCTGGTGGAGGCGCACGGCACCGGCACCCGGCTCGGCGATCCGATCGAGGCCGGCGCGCTCCAGGCCACCTACGGCGCACCGCGCGCACGTCCTCTGGCGCTGGGCTCGGTGAAGTCAAACATCGGCCACACCCAGGCCGCGGCCGGTGTCGCCGGTGTGATCAAGGCGGTGCTGGCGATGCGGCACGGCGTCATCCCGCGCAGCCTGCACGCCGAGGAACTCTCCCCCGAGATCGACTGGTCGCCGGGGACGATCCGGGTCCAGCGGGAGAACGAGGACTGGCCGGCGGGCCCGCGGGTGCGCCGGGCCGGCGTGTCCTCGTTCGGGGTCAGCGGCACCAACGCCCACGTCGTCCTGGAAGAGGCCCCCGCGGTCCCGGAATCGGCACCGGCCGGCGCGGAAGCGGCCCCAGTGCTGCCGGAAGCGGTGGCCGCGAACGTGGCCGCACCGGCCGGGCGGCCTGGCGGACGCGGTCTCGCGGCGGACACCGCGGCACTCGTGCTCTCGGCCCGTACACCGAGCGCGGTGCGCGCGCAGGCCGGCGCCCTCGCGGCGCTGCTGCGCACCTCGCCGGCGACCCCCCTGGCCGACACCGCGCGGACGCTCGCGACCGGCCGGACCCGGTTGGACATCCGGGCCGCGGTACTGGGCGACGACCGGGACTCGGTGTGCGCGGCGCTCGACGCGCTGGCCGCCGGCGAGGCGGCCGCCGACGTCGTGCCGCCGCGCACGGCGGCCCCCCGCAAGGCCGTCCTGGTCTTCCCCGGCCAGGGCTCGCAGTGGGCCGGCATGGCCGCCGACCTCCTCGGCCAGTCGGAAATCTTCGCCGCCGCCATGGCCGACTGCGCGGCGGCGCTCGCCCCGTACACCGACTGGGACCTGCTCGCCACGCTGCGCGGCGACGGCCCCGAGGACGCCTTCGAACGGCCCGACGTCGTCCAGCCGCTGCTGTTCGCGGTCATGGTGTCGCTGGCGGCGCTGTGGCGCGCCCACGGCGTCGAGCCGGCCGCCGTGGTGGGCCACTCGCAGGGCGAGATCGCCGCCGCCTGCGTCGCCGGGGCCCTCACCCTCGACACCGCCGCGAAGGTCGTCGCGCTGCGCAGCAAGGTGCTCGGCGAGCTGAACGGGCAGGGCGGCATGGCCTCCGTCACCGCCGCGCCCGGCGAACTCCGCGAAGCCCTGGCCCCGTGGGACGGCCGGCTGAGCGTCGCCGCCGTGAACGGGCCGCGCTCCCTCGTCGTCGCCGGCGAGGCCGCCGCCCTCGACGAGTTCCTCGGCTCCCCGCGGGCCGAGGAGATGTCCCCGCGGCGGATCGCGGTGGGCTACGGCTCCCACTCCCCGCAGGTGGCACAGGTCGAGCAGCGGCTCGCCGATGTCCTGGGCACGGTCCCGGCCCGGTCCGCCGCCGTGCCCTTCTGCTCGACCGTCACCGGCGCACCGCTCGACACCGCCGGACTCGACGCCGCGTACTGGTACCGCAACCTGCGCGGCACGGTCCGCCTCGACCAGGCCGTACGCACCCTCATGGAGCAGGGCTTCGACACCTTCGTCGAGGTCAGCCCGCACCCGGTGCTGCTCCCCGGCATCGAGCAGACCGCCGAGGACCTCGGCCGGGACGTCGTCACCCTCGCCTCCCTGCGCCGGGACCGCCCCGGCGCGCGCACCTTCCTGCGCAACCTGCTGGAGGCACACGCCGACGGCCTGCCCGTCGACCTGCTGCCCGCCCTGGAACCCGGCGGGACGGCGGAACTGCCGACCTATCCGTTCGAGCACACCTCCTACTGGCCACGCCCCTGCCGCACCCGCGCCGACGCGGCACCCTCGGGCATGGACAGCGTCGCCCACCCCGTCCTGTCCGCAGCGCTGGAGACACCCGACGGCGGACACGTCCTGACCGGGCGGATCACCCTCGGGGACCAGCCGTGGCTGGCCGACCACGCCGTCGGCGGCGAGACCCTGCTGCCCGGCAGCGCACTGGTCGACCTCGCCCTGACGGCCGGCCGCCACGCGGGCACGCCGGCCGTGGCGGAACTGGTGCTCTGCGCCCCCCTGTTGCCCGGTGCGGCCACCGCCGTCCGCGTGACGGTCGGCGCCCCCGCGGCGGACGGCACCCGCACGGTGGACATCCACGCCCGCGACACGGACGCGCCGGGCACGCCCTGGACCCGGCACGCCACCGGCGTCCTCGGCGAGGCCGCGCCGCCGCCGGCCACCCCCGCGGTCTGGCCGCCGGCGGATGCCCGGCCGATCGACCTGGACGCGGCCTACGCACGCCTGGCCGACCGCGGTTACGGCTACGGGCCCGCCTTCCGGGCACTGCGCGCGGCCTGGCAGCGCGGCGCGGAGGTGTTCGCCGAGGCCGAACTCCCGGCGGCGGCGGGCCCCGACGACGCCGAGAGCGCGGGCTACCTGCTGCACCCCGTGCTCCTCGACGCCGCCGCCCAGACCCTCGGCCTCGGCCCCCTCGCCGACCGGGACGGCGCGTTCCTGCCCTTCTCCTGGACCGGGACCACGCTGTACGCGTCCGGGGCCACGACGATCCGGGTGAGCGCGGCCCCCGCCGGCGCCGACGCGATGAGCCTGTCGGTGACCGATCCCGCGGGAGCGCCGGTCGCCGTCGTGAGCGCCGTGACCGTGCGTCCGGTCGGCGGGGAGCCTGGCCCGCGCGCCGGGGAGGAGACCGGCGCCGACGACCTCTACCACCTGACCTGGCGGCCCCTGCCCGAGACCACCGGCCGGGCCGTCGGCTGCGCGACGATCGGCGGCCCCTGCGGACTCGGCAAGGACCACCCGGACCTGGCGGCACTGGCCGCGGCGGTCGCGGCCGGCGAGCCGGAACCCGAGGCCGTCGTCGTGCCGTGCCGTCCATGGCAGGCGGCGGACCCGGCCGGCTCCGTGCGCGAGAGTGTGCTGCACGCCGCCGGGCTCGTGCGCCAGTGGCTCGATGCGCCCGAACGCACCGGCCGCCTGGTGTTCCTCACCCGCAACGCCGTGAGCACCGGCCCCGCCGACACCGCGGCGGACCCCGCACAGGCCGCGGTCTGGGGCCTGGTCCGCTCCGCCCAGGCGGAGTCACCGGGGAACTTCGCGCTCGTCGACATCGCCGACGGCGCCGATCCCGCGGTCCTCGCCGCCCTCCCGGCCGTGCTCGACCACCCGCAGCTGGCCGTGCGCGGCGACCTCGCGCTCGTGCCCCGGCTGGCCTCGACGCGCACCGCCCCGGCCCTGCTGCCGCCCCGCACGCCCGCCCGCCTGGAGCCCGCCGGTACCTCCCTGGACGCCCTCGCGTTCGCGGCGGCACCGGACGCCGGCCGGCAGCCGGGACCGGGTGAGGTGCGGGTCGAACTGCGGTCCTGCGGAGTGAACTTCCGCGATGTCCTGATCGCCCTCGGCATGTACCCCGGTGCCGCCGTCATGGGCACCGAGGGCGCCGGGGTCGTCACCGCCGTCGGCCCGGACGTGACGGGCGTCGCGGTGGGCGACCGGGTCATGGGCCTGTTCGAAGGCGCCTTCGGGCCGGTCGCGGTCACCGACCACCGGCTGGTCACCCCGGTCCCGCCGGGATGGAGCACCACCGAGGCCGCCGCCCTGCCCATCGCCTTCACCACCGCCCACTACGCGCTGCACGACCTCGCCGGAGTGCGGCCCGGACAGGCCGTCCTGGTGCACGCCGCCGCCACCGGCGTCGGCATGGCCGCGGTCCGCCTGGCCCGGCTGGCCGGGGCGGAGGTCTTCGCCACCGCCAGCCCCGCCAAGCAGGGCGTGCTGCGCTCGCTCGGACTCGACGACGACCACATCGCCTCGTCCAGGGAGCCGGGATTCGGCCGGCGCTTCAGGGCCGTGCGCGGCGGACGCGGCATGGACGTTGTGGTCAACTCGCTGACCGGCGCACTGCTCGACGAGTCGGCCGAACTCCTCGCCGAAGGCGGTGCGTTCGTCGAGATGGGCAAGACCGACCTGCGCGACGCCGACCGGTTCCGCGGGCGCTACCTGCCCTTCGACCTCGCCGAGGCGGGAGCGGACCGGCTCGGCGCGATCCTCGCCGAGGTCGCCTCCCTGGCGGCCGGCGGCGAACTCGGCCGCCAGACGGTCACGGCCTGGCCGCTGCAACGGGCGTCGGCCGCCCTCCAGCACATGAGCACGGGACGGCACACCGGAAAGCTGGTGCTCGTCCAGCCGGCCCCGCTCGACCCCGAGGGCACCGTGCTCGTCACCGGCGGCACCGGCACCCTGGCCAGGCTGCTGGCCCGCCATCTCGTGACCGAGCACGGCGTACGCCATCTGCTGCTGCTCGGCCGCCGCGGGCCCGACGCGCCGGGAGCGGCCCGGTTCGAAGCCGAACTGGGCGAACTGGGCGCGACCGTGACCACGCGCGCCTGCGACGTCTCCGACCGCGCCGCGCTCGCCGCCGCGCTCGACGGCATCCCGGCCGGGCACCCGCTGACCGGCGTCGTGCACACCGCGGGCGTGCTCGCCGACGGCCTGGCCGCGTCCCTCGGCGAGGACGAACTGGGCACGGTCCTCGCGCCCAAGGCGGACGCCGCATGGCATCTGCACGAACTCACCGCGGACCGCGAACCGAACTTCTTCGTCCTGTTCGGTTCGGGCGCCTCCGTGCTGGCCGGACCGGGCCAGGGCGCGTACGCGGCGGCCAACGCCGCACTGGACGCGCTGGCCCGGTACCGGCAGGCCCGCGGGCTGCCCGCGACGTCCCTCGGCTGGGGGCTGTGGGAGGAGGCCAGCGGCCTGACGGGCGCTCTGGACGAGCGGGACACCCGGCGGATGGCCCGCGCGGGCATGCGGCCCCTGCCGACCGCGCGGGCGCTGGCCCTGTTCGACCTCGCGATCCGGCGCGGCGATGCGGTGGCGTACCCGCTGCACCTGGACACCGCGCGGGCGCAGGGCGCCCAGGACGCGCCCGAGGTGCTGCGCGGGCTGCTGCACACGCCGCTGCGCCGGGCCGCGCGGGACCAGTCCGGCGGTGACGGACTCGCCGCCCGCCTGGCGCCGCTGCCGCGCCCCGACCGGCTCGCCGCGCTGACCCATGCCGTACAGGCGCAGGCCGCCGCCGTCGCCGGGTACGACACGGCCGACGCGGTGGCAGCCCGACGGCAGTTCAAGGACCTCGGCTTCGACTCCCTGGCCTCCGTCGAACTGCGCAACCGGCTGGGGTCCGCGCTCGGCCTGCGGCTGCCGAGCACTTTGGTCTTCGACCACCCGACACCCGAGGCGGTGGCCGTCTTCGTGGACGGTCGGCTGTTCGCCGGCGCGGACGCGGCCGGCGCCCCGGCGCCGGAGCCGGGGCGCTCCGTCGCCGAGCACCTGGCGGCGCTGGAGGCGGTGCTGGAGGGCTGGCAGGAGGCCGGCGAGGACACGGCCGGTGAACGCCGGGCCATCGGGGCGCGGTTGACGGCCCTGTCCGACCGATGGAGCGCCGTGGCCGCCGGGGACTCCCGCACGGCCGTCGACACCGTCGACGACGAGGAACTGTTCGCACTGCTCGACCAGCGGTTCGGTGAGGGGAACGAGGAACGATGA	VTDNDKVASYLRRATLDLRAARRRIHELEADPVAIVGTACRLPGGIETPEAFWEVLAAGEERLSAFPEDRGWDLTGLYHPDPDHPGTTYVRTGAFLERAGEFDAAFFGVSPREAAAMDPQQRLLLETSWELIENAGLDPHSLRGTDTGVFLGVARHGYGDTGGSAEDAEGYTVTGAAPSVASGRIAYTLGLEGPAITLDTACSSSLVALHLAVASLRRGECGLAIVGGAAVMAGPEVFVDFARQRALAADGRSKAFGAGADGFGFGEGVAVLLLERLSDARRRGHTVLAVVRGTGINQDGASNGLAAPSRAAQRKVIEQALANAGVAPGDVDAVEAHGTGTTLGDPIEAHALLDTYGRGRGPQRPLWLGSAKSNIGHTQGAAGAVGVLKMVLALRHERLPRTLHAEEASPHVDWSSGAVALLAEEQHWPRGERPRYAAVSAFGISGTNAHVVLQEAPAPEETGERAAPRPATPQHPVPLVVSARSEEALRAQARRLSDVLADTDAELPGIGLTLATARARHEHRAVVVAGSRDLALHGMREVAAGAARLTGTVESGGRSAVFLFPGQGSQWAGMGADLLAWSPVFAETIRACDEAMAPWQDWSVAAVLRQQPGAPGLDRVDVVQPALFAVMVSLAALWRSYGVEPAAVAGHSQGEIAAAYVAGALTLEDAARLVVLRSRLLRSLAGKGAMAAVALDEAAVRELLVPYAGAVEVAAVNGPASVVVSGEPAAVDSLVADCAGRGARARTIDVDYASHSAQMEEVREELAAALRDLRPGRARVPFYSTVTGRPMDGGELDAGYWYRNLREPVRLHDVVRLLADAHHDTFIEVSPHPVLAATVEETLEAAGREPGAALALGTLRRGAPGPESFLTFAASAHVEGVDVRWQPAFGDDARPVALPTYPFQRKHYWTAPAGPARATGGVTYRVSWTPLPAPEPADARGPWLIVGPAASPAWAGLLPAAVREAGGTPLECALDPGLDRAGAAAALTAALAGTTGVRGVLSLLAADESDHPGRPGVPVGAVATLTLAQALADAGVDAPLWCLTRGAVQTDEDDGIGSYAQNAVHGLGRVAGLELGRRWGGVLDLPHPDGADAALLGRVPGLLAGAHAAEDHLALRPGGLYGRRLVPVRTPATTDGTGPRLHGTVLLTGADSPIGARLARWAADSGADHLLLVGEADEELLNALRERGTTATRCAADEDALRAAVEAAPHDISTVVHAATRTEFGPVLATDPEDFAATLQAKTGLALTLAAVLDGRPVEREIHCSSVAGVWGGAGMAGYAAGSACLDAFAAHRRAQGHPSTAVAFSPWALPGTVPSAPQAAQRGLRGLSADRALAALTSALDSGESAVAVSDVDWPAFAAGFGAVRPTALFAEISEARETAEPPAAPAAPDGSPAADLAARLTARTPAQREELLIGVVAEATAAVLGHDSAEDVSARRAFTELGLDSLGSVQLRKRLSAATGLRLPASLVFDHPTVTRLARHLLSLLAADSGPELAAAVGSAPPSAEDEPIAIVGMSCRFPGGIGSPEELWRAVVDGQDLTGELPRDRGWELGALYHPDPDHPGTSYSDRGGFLADAAGFDAEFFGITPREALAMDPQQRLMLEVAWEAVERGGIDPDALRGSRVGVFVGSNGQSYMPLLRGEADRVEGYQGLGNSASVLSGRLAYTFGWTGPALTVDTACSSSLVGIHLAIRALRDGECAMALAGGVTVICDPYTFVDFSRQRGLAADGRCKPFSAQADGFGLAEGAGALLLEPLSRAIESGHPVLAVLRGSAVNQDGASNGLAAPNGPAQEEVIRQALADARLSAADIDLVEAHGTGTRLGDPIEAGALQATYGAPRARPLALGSVKSNIGHTQAAAGVAGVIKAVLAMRHGVIPRSLHAEELSPEIDWSPGTIRVQRENEDWPAGPRVRRAGVSSFGVSGTNAHVVLEEAPAVPESAPAGAEAAPVLPEAVAANVAAPAGRPGGRGLAADTAALVLSARTPSAVRAQAGALAALLRTSPATPLADTARTLATGRTRLDIRAAVLGDDRDSVCAALDALAAGEAAADVVPPRTAAPRKAVLVFPGQGSQWAGMAADLLGQSEIFAAAMADCAAALAPYTDWDLLATLRGDGPEDAFERPDVVQPLLFAVMVSLAALWRAHGVEPAAVVGHSQGEIAAACVAGALTLDTAAKVVALRSKVLGELNGQGGMASVTAAPGELREALAPWDGRLSVAAVNGPRSLVVAGEAAALDEFLGSPRAEEMSPRRIAVGYGSHSPQVAQVEQRLADVLGTVPARSAAVPFCSTVTGAPLDTAGLDAAYWYRNLRGTVRLDQAVRTLMEQGFDTFVEVSPHPVLLPGIEQTAEDLGRDVVTLASLRRDRPGARTFLRNLLEAHADGLPVDLLPALEPGGTAELPTYPFEHTSYWPRPCRTRADAAPSGMDSVAHPVLSAALETPDGGHVLTGRITLGDQPWLADHAVGGETLLPGSALVDLALTAGRHAGTPAVAELVLCAPLLPGAATAVRVTVGAPAADGTRTVDIHARDTDAPGTPWTRHATGVLGEAAPPPATPAVWPPADARPIDLDAAYARLADRGYGYGPAFRALRAAWQRGAEVFAEAELPAAAGPDDAESAGYLLHPVLLDAAAQTLGLGPLADRDGAFLPFSWTGTTLYASGATTIRVSAAPAGADAMSLSVTDPAGAPVAVVSAVTVRPVGGEPGPRAGEETGADDLYHLTWRPLPETTGRAVGCATIGGPCGLGKDHPDLAALAAAVAAGEPEPEAVVVPCRPWQAADPAGSVRESVLHAAGLVRQWLDAPERTGRLVFLTRNAVSTGPADTAADPAQAAVWGLVRSAQAESPGNFALVDIADGADPAVLAALPAVLDHPQLAVRGDLALVPRLASTRTAPALLPPRTPARLEPAGTSLDALAFAAAPDAGRQPGPGEVRVELRSCGVNFRDVLIALGMYPGAAVMGTEGAGVVTAVGPDVTGVAVGDRVMGLFEGAFGPVAVTDHRLVTPVPPGWSTTEAAALPIAFTTAHYALHDLAGVRPGQAVLVHAAATGVGMAAVRLARLAGAEVFATASPAKQGVLRSLGLDDDHIASSREPGFGRRFRAVRGGRGMDVVVNSLTGALLDESAELLAEGGAFVEMGKTDLRDADRFRGRYLPFDLAEAGADRLGAILAEVASLAAGGELGRQTVTAWPLQRASAALQHMSTGRHTGKLVLVQPAPLDPEGTVLVTGGTGTLARLLARHLVTEHGVRHLLLLGRRGPDAPGAARFEAELGELGATVTTRACDVSDRAALAAALDGIPAGHPLTGVVHTAGVLADGLAASLGEDELGTVLAPKADAAWHLHELTADREPNFFVLFGSGASVLAGPGQGAYAAANAALDALARYRQARGLPATSLGWGLWEEASGLTGALDERDTRRMARAGMRPLPTARALALFDLAIRRGDAVAYPLHLDTARAQGAQDAPEVLRGLLHTPLRRAARDQSGGDGLAARLAPLPRPDRLAALTHAVQAQAAAVAGYDTADAVAARRQFKDLGFDSLASVELRNRLGSALGLRLPSTLVFDHPTPEAVAVFVDGRLFAGADAAGAPAPEPGRSVAEHLAALEAVLEGWQEAGEDTAGERRAIGARLTALSDRWSAVAAGDSRTAVDTVDDEELFALLDQRFGEGNEER	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	1078.47	gnl|BL_ORD_ID|1039|hsp_num:0	1041			75	732	ciprofloxacin; trimethoprim; chloramphenicol
BGC0000085.1|Lankamycin_13 # 43447 # 44670 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.717	BGC0000085.1|Lankamycin_13 	43447	44670	+	Loose	175	26.1794	vanT gene in vanG cluster	26.19	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGGACGAAACCCTCAAGCCCTCCCCTGCCGACGCGGCCGGCACAGCGGGAGGCCGGGCCGACCGGCTGCCGTCGCTGACGGGGCTGAGGTTCTTCGCCGCGCTCCTGGTGTTCGTCTGCCATGCGTGGAGCCAGTTCAACCCGCAGGCCGACACCGCCTCGCGAAACCTGGCCTACTTCCTGCTGCCGGCCGGCCCCGTCGGGGTCTCCTTCTTCTTCGTCCTCAGCGGGTTCGTGCTGACGTACGCGGCGCGGCCGGGCGATACCGTTCTCGGCTTCTGGCGGCGGCGGATGGCGAAGATCTACCCGAACCATGTCGTGACGTGGGTGGCCGGTCTCGTCCTGGTCCTCGCCACGGGCGCCGCCCTGTCGGCCGGGACGACGGCCGCCGCCCTCTTCCTCGTGCAGGCGTGGTGGCCGCACATGATCATGACCGCCACGGTCAACCCGATCTCGTGGTCGCTCGCCTGCGAGCTGTTCTTCTACCTGCTGTTCCCCTTCCTGCTCCGGGCCGTGCGCCGGCTGCCGCGGCAGGGGCTGTGGCCGGCCGCGGGCCTGCTGACGGCGCTGATCCTGGCCGTACCGCAGCTGGCCACTCTGCTGCCCGGCAAGGTCATGCCGCTGGCGGGGTACAGCCTCACGCAGTTCTGGTTCGTCTACACCGCGCCCCCGGTGCGCCTGCTGGAGTTCGCGCTCGGGATCGTGCTCGCTCTCCTTGTGCGCAACGGCATGTGGCCCCTCGTCAGCGTCCGGCTCGCCGTCGTCCTGTGCTGCGCCGGGTACGCGGTGGCCGGTGTCACGACGATGGTCACCAAGCTGCCCCACCTGTGGGCGATGGTGAGCGCCACCGTCATCCCGCTGGCGGTCCTCATCGCCACGGCCGCCTCCCGCGACCGGAGCGGCCTGCCCTCCGCCGCCCGCCATCCGCGCCTGATCCGGCTGGGCGAACTCTCCTTCGCCTTCTACCTGGTGCACCACATGATCCTGACGGCCTGCTTCACCGCCGTGCTGCCGGACGGCTTCCGGCCGGGTCTGCTCGGGCTCACCGGCGTGGCCGTCGCGCTGTTCTTCGTCTGCTGGGCGGCGGCCTGGCTCCTGCACACCGCGGTCGAGACACCCGCCATGCGCCGCTGGGGCCGCCCTCCGGCGACCGCCCGCGCGCCCCGTGAGCCGGCCCGCGCATCCGGGCGATCCGAACCCCTCACCGGTGAAAGGACACCATGA	MDETLKPSPADAAGTAGGRADRLPSLTGLRFFAALLVFVCHAWSQFNPQADTASRNLAYFLLPAGPVGVSFFFVLSGFVLTYAARPGDTVLGFWRRRMAKIYPNHVVTWVAGLVLVLATGAALSAGTTAAALFLVQAWWPHMIMTATVNPISWSLACELFFYLLFPFLLRAVRRLPRQGLWPAAGLLTALILAVPQLATLLPGKVMPLAGYSLTQFWFVYTAPPVRLLEFALGIVLALLVRNGMWPLVSVRLAVVLCCAGYAVAGVTTMVTKLPHLWAMVSATVIPLAVLIATAASRDRSGLPSAARHPRLIRLGELSFAFYLVHHMILTACFTAVLPDGFRPGLLGLTGVAVALFFVCWAAAWLLHTAVETPAMRRWGRPPATARAPREPARASGRSEPLTGERTP	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	57.16	gnl|BL_ORD_ID|1522|hsp_num:0	1561			6	246	vancomycin
BGC0000085.1|Lankamycin_14 # 44667 # 45881 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	BGC0000085.1|Lankamycin_14 	44667	45881	+	Loose	700	28.4906	ACC-4	25.64	3001818	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	ACC beta-lactamase	ATGAACCAGCCGCAACTGCCCGAGATCCCGGCCCTGAACAGCGAGCTGTTCCACACCGACCAGTACGCGACCTACCGGGAGATCCTGGAGCAGCGTCCGGTCACCAGGGTCCGCTTCTACGACGGTTCCCTGGTCTGGCTGGTCAACCGCCACGAGGACGTACGGGCCGCGCTGACCGACCCCCGGCTGAGCAACGACCCCATGAAGCAGTCGGACATCGACCTCTCGGCGGCCACCGGCATCCCGGCCGACCTGATCGAGTACTTCCAGCGGAACATGTTCCGCAGCGACGAGCCGGACCACGGCCGGCTGCGCAAGCTGGTCACCAGGGAATTCACCGTGCGGCGCATCAACGCGCTGCGGCCGCGGATCCGGCAGATCGCCGACGACCTGCTGGAGAAGTTCGCCGCCACCGGCGGCGGGGACCTGGTGGAGGCGCTCGCCCGCCCGCTTCCGCTCACCGTCATGTGCGAACTGCTCGGCGTGCCCGAGGAGGACCGCGCGGACTTCCAGACCTGGTCCCAGCACATCGTCGAGAGCAGCCCGGAGTTCGCGGAGCGCAACGCCGTCTCGTACCGCAGCCTGTTCGAGTGCGTCCGCTCCCTGATCCGCCGCCGGCGCGACGAACCGGGAGACGACCTGCTGTCGGCACTGGTCGACCTGCGCGACGTGGCGGACCGGCTCTCCGAGAACGAACTCATCTCGACGGTGTTCCTGCTGCTCGTCGCGGGGATCGAGACCACGGTGAACGTGCTCGGCACCGGCACCTTCCTGCTGCTGACCCACCCCGGCGAGCTCGCCCGGCTCCGCGCGGACGGCGCGCTGCTGGGGCCGGCCGTGGAGGAGATGCTGCGCTACATGGCACCCATCGAGATCACGAGCCGGCACACCCTGGAGCCCGTCGAGATCGGCGGGGTGTCCATCGACGCGCAGAGCACCGTGCTCATCAACCTGGCCGCAGCCAACCGGGATCCGGCGCGGTTCGAGGACCCGCAGTCCTTCCGGGTCGACCGCAACGACGGCGGCCACCTCACCTTCGGCCACGGCATCCACTACTGCCTGGGCGCCGCGCTGGCACGGGCGGAGGCGGAAGTCACCTTCGAGGCCCTCCTGGAGCGCTTCCCGGACCTGCGACTGGCCGCTTCCGCATCCGACCTGACCTGGCGCCACGCCTTCATGCGGGGCCCGGTCGAGCTGCCCGTCTCCTGGGGGTGA	MNQPQLPEIPALNSELFHTDQYATYREILEQRPVTRVRFYDGSLVWLVNRHEDVRAALTDPRLSNDPMKQSDIDLSAATGIPADLIEYFQRNMFRSDEPDHGRLRKLVTREFTVRRINALRPRIRQIADDLLEKFAATGGGDLVEALARPLPLTVMCELLGVPEEDRADFQTWSQHIVESSPEFAERNAVSYRSLFECVRSLIRRRRDEPGDDLLSALVDLRDVADRLSENELISTVFLLLVAGIETTVNVLGTGTFLLLTHPGELARLRADGALLGPAVEEMLRYMAPIEITSRHTLEPVEIGGVSIDAQSTVLINLAAANRDPARFEDPQSFRVDRNDGGHLTFGHGIHYCLGAALARAEAEVTFEALLERFPDLRLAASASDLTWRHAFMRGPVELPVSWG	MQNTLKLLSVITCLAATVQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVTVNGKNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYVPELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIGTGLLGMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHGNMEILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWEQLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVMLANKNYSIDQRVTVAYKILSSLEGNK	104.66	gnl|BL_ORD_ID|367|hsp_num:0	406			636	753	
BGC0000085.1|Lankamycin_15 # 45886 # 47085 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=7bp;gc_cont=0.708	BGC0000085.1|Lankamycin_15 	45886	47085	+	Loose	700	25.409	tet(A)	32.39	3000165	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAGCGCGCGCTCACCGATCTCGCGGTCTTCGGGGGTCCCGAGGCGTTCCTGCGCCCGCTCCTGGTGGGCATGCCCACCGTCGGCGACCGGGCGCGGTTCCTCGCCCGGCTCGAATGGGCCCTGGACAACGAGTGGCTGACCAACGGCGGCCCGCTGGCCACCGAACTGGAGGGCCGCATCGCCGACATCGCCGGGGTGCGGTACGCCGTGGCGACCTGCAACGCCACCGCGGCGCTGCAACTGGTCCTGAAGGCCTCGGGCATCACCGGACAGGTGATCATGCCCTCGCTGACCTTCGCGGCGACTCCGCACGCGGCGAGCTGGGTGGGGCTCGAACCGGTGTTCTGCGACGTCGACCCGGTCACCGGCTGCCTCGACCCCGGCCGGGTCGAGAAGCTGATCACCCCCGAGACCGGGGCCATCCTCGGCGTCCACCTGTGGGGCCGGGCGGCCCCGGTCCTGGAGCTGGAGAAGCTGGCCGCCGAGCACGGGCTGCGACTGTTCTTCGACGCGGCCCACGCCTTCGGCTGCACCGCCGGCGGACGGCCGGTCGGCGGCTTCGGGGACGCGGAGGTGTTCAGCTTCCACGCCACCAAGACGGTCATGGCCTTCGAGGGCGGCGCGGTGACCACCGACGACGGCGAACTGGCCGAACGGCTCGTGGCCCTGCGCAACTTCGGCATCGACCGGGACAAGTCCGTGACCGCGGTCGGCATGAACGCCAAGATGAGCGAGTGCTCGGCCGCCATGGGTCTGACCTCCCTCGACGCCTTCCCGGCGACCCGCGAGCGCAATCGTGAGAACCACGCCCTCTACCAGGCGGAACTGACCGGCGTCCCCGGCACCGAGGTGCTCTCCTTCCACGAGCACGAACGCAACAACCACCAGTATGTGATCCTGCGGACGGACCGCGCCGTCACCGGTCTGCACCGCGACCGGCTGCGGGCCCTGCTGCAGGCCGAAAAGGTCTTCCCCCAGCTGTACTTCTCACCCCCCTGCCATCTGATGCCCGCCTACCGGACCGACCCCCCGCTGCGGCTGGAACACACCGAGCGCCTGTCCGAGCAGGTACTCGCGCTGCCCACCGGGCCGTCGGTGTCCTTCGAGGACATCCGCCGGGTGTGCAGCATCATCCGGCTCGCCGCGGAGCGCGGCGCGCAGATCGATGCGATGTGGGCCCAAACAGCGCTCTCCTGA	MKRALTDLAVFGGPEAFLRPLLVGMPTVGDRARFLARLEWALDNEWLTNGGPLATELEGRIADIAGVRYAVATCNATAALQLVLKASGITGQVIMPSLTFAATPHAASWVGLEPVFCDVDPVTGCLDPGRVEKLITPETGAILGVHLWGRAAPVLELEKLAAEHGLRLFFDAAHAFGCTAGGRPVGGFGDAEVFSFHATKTVMAFEGGAVTTDDGELAERLVALRNFGIDRDKSVTAVGMNAKMSECSAAMGLTSLDAFPATRERNRENHALYQAELTGVPGTEVLSFHEHERNNHQYVILRTDRAVTGLHRDRLRALLQAEKVFPQLYFSPPCHLMPAYRTDPPLRLEHTERLSEQVLALPTGPSVSFEDIRRVCSIIRLAAERGAQIDAMWAQTALS	MSTNLSVIKNPRVQSDQRRLVRRPDVKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPALRRGLWRNSSNSRCT	94.10	gnl|BL_ORD_ID|1792|hsp_num:0	1808			354	546	tetracycline
BGC0000085.1|Lankamycin_16 # 47128 # 48600 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.731	BGC0000085.1|Lankamycin_16 	47128	48600	+	Loose	600	25.7942	ALG11-1	27.14	3006892	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ALG11 beta-lactamase	GTGGACACCGTCCAAGCGGCAGCGCCCGCCCCCGCGATACAGGACGCGGCACGCCCCGGAGGCGACCGTGCAGCGGCGATCGAGGCGGTGCGCATCCGCCTCGGCCAGCTCGGCGACACCGGCGACGGGGCCCGGCAGCGGGCGGAGCACCTCGTCGACCTGGCGACGCGGTACGGCTCCCACCCGTTCACCACCCTGGAAGAGGCCCGCCACCTGCTGGGCGTGGACCGCCCGGCCTTCGCCGCGCTGCTCGGTCTCTTCCACCGGGTACCCGAGCTGAGCACGGCCGTGCAGCGGGGCCCGCAGGGGAAGTACTGGACCAACACCATCCTGCCGCTGGAGCGGACGGGCGCGCTCGACGCCGCGGTACACGGCCGCCCGGCCTTCCCCTACAGCGTCGGTCTGTATCCGGGGCCGACCTGCATGTTCCGCTGCCACTTCTGTGTGCGCGTCACCGGCGCGCGCTACGAGACGTCCGCGCTCAAGGCGGGCAACGCCATGTTCGCGTCCGTCATCGACGAGGTGCCCGAGACACAGCCCTCGACGGTCTACTTCTCCGGCGGGCTGGAACCGCTCACCAATCCGGGGCTGGGCGAACTCGCGGCGCGCGGCGGCCGGCGCGGCCTCGACATGACGCTGTACACCAACGCCTACGCGCTCACCGACCGCACGCTGGAGCGCCAGCCGGGGCTGTGGTCGCTGCACGCGATCCGCACCTCGCTGTACGGGCTGAGCGACGAGGAGTACGAAGCCACCACGACCAAGCCGCGCGCCTTCGGGCGGGTCAGGGAGAACCTGGGCGCGTACATGGAGAGGCGGGCGGAGCACGGCGCCCCGACGCGGCTCGGCCTCAACTACATCATCCTGCCCGGCCGGGCCGACCGGCTCATGGACCTCGTGGACTTCGTGGCCGGCCTGGACGAGCGCTCCCCCGGCCGTCCTCTCGACTTCGTGACGGTGCGCGAGGACTACAGCGGGCGGGACGACGGCCGGCTCGCGGCCGACGAGCGCGCCCGGCTGCGCGACGCGCTGCGGGACTTCACCGCGTACGCGCGGGAGCGGACGCCCTCGCTGCACATCGATCTGGGGTACGCCCTGGAGAGCCTGCGCAGCGGGGTGGACGCCCGGCTGCCGCGCATCACCCCGGCGGCCATGCGCGGTTCCGCGCACCCGCAGATCGCGGTGCAGGTCGACCTTTTGGGCGACGTGTACCTCTACCGCGAGTCGGGCTTCCCCGGCCTGGCCGGCGCGGACCGCTACATCGCCGGACGCGTCACCCCGGACAGGAGCCTGCACGACGTCGTCCGCGCGTTCGTCGAGAGCAATCCGCATATCGAGCCGCGGCCCGGCGACGAGTTCTTCCTCGACGGATTCGACCAGGTCGTGACGGCCCGGCTGAACCAGATGGAGCAGGACGTCGCCGACGGCTGGGGGGCGTACCGGGGCCTGCTGGGCGCGGACGCTCCGGCGTGA	MDTVQAAAPAPAIQDAARPGGDRAAAIEAVRIRLGQLGDTGDGARQRAEHLVDLATRYGSHPFTTLEEARHLLGVDRPAFAALLGLFHRVPELSTAVQRGPQGKYWTNTILPLERTGALDAAVHGRPAFPYSVGLYPGPTCMFRCHFCVRVTGARYETSALKAGNAMFASVIDEVPETQPSTVYFSGGLEPLTNPGLGELAARGGRRGLDMTLYTNAYALTDRTLERQPGLWSLHAIRTSLYGLSDEEYEATTTKPRAFGRVRENLGAYMERRAEHGAPTRLGLNYIILPGRADRLMDLVDFVAGLDERSPGRPLDFVTVREDYSGRDDGRLAADERARLRDALRDFTAYARERTPSLHIDLGYALESLRSGVDARLPRITPAAMRGSAHPQIAVQVDLLGDVYLYRESGFPGLAGADRYIAGRVTPDRSLHDVVRAFVESNPHIEPRPGDEFFLDGFDQVVTARLNQMEQDVADGWGAYRGLLGADAPA	MAASAAVSLVVFLFVFVFTFAHAQDQPASWAQPQKPVRIFGNTWYVGTRGLSAILITSPTGAVLIDGAVREAASDIASNITSLGVRLEDIKLIVNSHAHNDHAGAIAELQRRTGATVAALPWSAEALRSGRKHQGDPQFESPTSPPDRVANVKTIQDGEVLRAGGVEVTAHKTAGHTPGGTTWTWRSCEENRCVDIVYADSLTAVSADGFRFTDNKTYPQAIDDFNKGYAFLRSASCDILVTPHPEASDFWGRIAKRDAGERDALIDRSQCARYADRADAQLQKRLATERAERPK	166.10	gnl|BL_ORD_ID|3289|hsp_num:0	4358			249	459	
BGC0000085.1|Lankamycin_17 # 48615 # 49892 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=9bp;gc_cont=0.741	BGC0000085.1|Lankamycin_17 	48615	49892	-	Loose	700	58.9214	oleD	27.27	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGTGTGCTCATCGCGGCTTTCGCACACACCTCGCACTTTCACGGCATGGTGCCCCTCGCGGGGGCGCTGCGTGCCGCGGGACACGATGTGCGCGTGGCCAGTCAGCCCGGCTTCGCGGACGAGATCACCGGCGCCGGGCTCACGGCCGTACCCGTGGGGGCGGACCACCGGCTGATGGAGGCGATGCAGGAGAAGGGCGCGGAGATCCAGCGGTACTCCGCGGACATCGACCTGTCCCGCCCCGAAGTCTTCGACTGGGACTACGTGTTCCGTCTGTACGACCTGTCGGTGCCCTACTTCTACTCGGTGATCAACGACGAGTCGTTCGTCCGGGAGCTGGTCGGGTACGCCCGCCGGTGGCAGCCGGACCTGGTGCTGTGGGAGCCGTACACGTTCGCCGGGGCCATCGCGGCGCGGGCGTGCGGCGCCGCCCACGCCCGTGTGCTCGGCGCGAGCGACCTGAACGCCTACTTCCGCCGGACGTTCCTCGACCGGCTCGCCGAGCAGCCCGCCGGACGGCGCCCCGACCCGCTGCGGGAGTGGCTGGCGGACGCCGCCGGGCGCCACGGGGTGCCGTTCGACGAGGAGCTGGTGGTCGGCCAGTGGAGCGTCGACCTGCTGCCCGAGCGGTTCCGGCTCGACCTGTCGCTGCCGACGGTGCCGCTGCGGTACGTGCCGTACAACGGCCGGGCCGTCGTGCCGGACTGGCTGCGCACGGCCGGGCCCCGGCGCCGGGTGTGCCTGACGACGGGCTCCACGGGGACCGGCTTCACCGCCGACCCGGCCGTCTTCCACCGTTACCTCCGGGTGCTCGCGCAGGTCGACGCGGAGATCGTCGTCACCGCCGACGCCGCCGCCCTGCGGGCGGTCGGCCCCCTGCCGGACAACGTCCGGGTCGTCGGCTTCGCCCCGCTGGACGTCCTGTTGCAGACGTGCGCGGCGGTGGTCCACCACGGTGGCTTCGGCACCTGGTCGACCGCCCTGTACCACGGGGTGCCGCAGGTCATGGTGCCGTTCATCTGGGACACCGTCCTGCGGGCGCAGCAGACGGCCGCCGCCGGCGCCGGCCTGTTCCTGCGGGAGGGCGAGGTGACCGCCGAGGGCCTGCGGGACAGCGTGGCGCGGGTGCTCGCCGAACCCTCCTTCCTCGACGGGGCCCGCCGGCTGCGGGGCGAGGCCCGCGCGGAGAGCAGCCCCCACGACGTGGTGCCGGTGCTGGAGGAACTCACCGGCAGGCACAGGGCCGCCGTGCCCGTGGCGGCGGCCGCGGGCTGA	MRVLIAAFAHTSHFHGMVPLAGALRAAGHDVRVASQPGFADEITGAGLTAVPVGADHRLMEAMQEKGAEIQRYSADIDLSRPEVFDWDYVFRLYDLSVPYFYSVINDESFVRELVGYARRWQPDLVLWEPYTFAGAIAARACGAAHARVLGASDLNAYFRRTFLDRLAEQPAGRRPDPLREWLADAAGRHGVPFDEELVVGQWSVDLLPERFRLDLSLPTVPLRYVPYNGRAVVPDWLRTAGPRRRVCLTTGSTGTGFTADPAVFHRYLRVLAQVDAEIVVTADAAALRAVGPLPDNVRVVGFAPLDVLLQTCAAVVHHGGFGTWSTALYHGVPQVMVPFIWDTVLRAQQTAAAGAGLFLREGEVTAEGLRDSVARVLAEPSFLDGARRLRGEARAESSPHDVVPVLEELTGRHRAAVPVAAAAG	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	102.41	gnl|BL_ORD_ID|1253|hsp_num:0	1367			672	1224	erythromycin; tylosin
BGC0000085.1|Lankamycin_19 # 51041 # 51961 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.744	BGC0000085.1|Lankamycin_19 	51041	51961	-	Loose	1650	25.7942	Streptococcus agalactiae mprF	40.0	3003774	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGCTGCCCGCGCTCGCCTGCCATCCCGGCGTCGAGGTGGTCGCGATCGGGAGCCGGGACGCGGCCAAGGCGGCCGTGTTCGCCCGGCGGTTCGGCGGCGAGCCGGTGACCGGGTACGAGGCCGTGCTCGACCGGTGCGACCTCGACGCCGTCTACATCCCGCTGCCACCCGCGCTCAACGCCGAGTGGACCCGGCGGGCACTGGAGGCGGACAAGCACGTCCTGTGCGAGAAACCCATGACCGTCTCCGCACGGCAGGCGGCCGAACTCCGGGACCTCGCCCGCGCCCGCGCCCGCGCCCTGTTCGAGAACTACATGTTCCTCTGCCATCCCCAGCACCGGGTGGTCGACGACCTGGTCGCCGCCGGAAGGATCGGTGAAATCCGTTCCCTGACAGCTGACTTCACCATTCCCGGCAAACTGCCCGGCGACATACGCCACCGCCGGGACCTGGGCGGGGGCGCGCTCACCGGCGTCGGCGGCTATCCGCTGCGCACCGCCCTGCGCTACCTCGGCCCCGGCCTGCGGGTCGTCGGCGCGCATCTGAAGCGGGACGCGCGCACCGGCGTCGACACCGGCGGGGCGGCGCTGCTCGCCGCGCCCGGCGGCGCCGTGGCCCACCTCGGGTTCGGACTGGAACACGCCTACCGCGGCCGCTACGAACTGACCGGGTCCACCGGACGCATCGTCGTCCCCAGGGCCTACACACCGCCCCCGGACCACACCGCCGTCGTCCGCCTCGAACGGGACGGATCCCACGAGGAGTTCGCCGTGCCCCCGCACGACCAGTTCCGCTCCGTGCTGACGGCCTTCGCCGAGGGCATCCGCTCGGGCACCCCGTCCCCGCTCACCGGCCGGGCCCTGACGGACCAGGCCGCGCTGGCCGAGGACGTCTACGCGGCCGCGCGGCGCGGCGGCTGA	MLPALACHPGVEVVAIGSRDAAKAAVFARRFGGEPVTGYEAVLDRCDLDAVYIPLPPALNAEWTRRALEADKHVLCEKPMTVSARQAAELRDLARARARALFENYMFLCHPQHRVVDDLVAAGRIGEIRSLTADFTIPGKLPGDIRHRRDLGGGALTGVGGYPLRTALRYLGPGLRVVGAHLKRDARTGVDTGGAALLAAPGGAVAHLGFGLEHAYRGRYELTGSTGRIVVPRAYTPPPDHTAVVRLERDGSHEEFAVPPHDQFRSVLTAFAEGIRSGTPSPLTGRALTDQAALAEDVYAAARRGG	MLKKLIEKVKSLTSVIKIVFFISVLVLIIVEMIHLKRTISVEQLKSVFGQLSPMNLFLIILVGVIAVLPTTGYDFVLNGLLRTDKSKRYILQTSWCINTFNNLSGFGGLIDIGLRMAFYGKKGQEKSDLREVTRFLPYLISGLSFISVIALIMSHIFHAKASVDYYYLVLIGASMYFPVIYWISGHKGSHYFGDMPSSTRIKLGVVSFFEWGCAAAAFIIIGYLMGIHLPVYKILPLFCIGCAVGIVSLIPGGLGSFELVLFTGFAAEGLPKETVVAWLLLYRLAYYIIPFFAGIYFFIHYLGSQINQRYENVPKELVSTVLQTMVSHLMRILGAFLIFSTAFFENITYIMWLQKLGLDPLQEQMLWQFPGLLLGVCFILLARTIDQKVKNAFPIAIIWITLTLFYLNLGHISWRLSFWFILLLLGLLVIKPTLYKKQFIYSWEERIKDGIIIVSLMGVLFYIAGLLFPIRAHITGGSIERLHYIIAWEPIALATLILTLVYLCLVKILQGKSCQIGDVFNVDRYKKLLQAYGGSSDSGLAFLNDKRLYWYQKNGEDCVAFQFVIVNNKCLIMGEPAGDDTYIREAIESFIDDADKLDYDLVFYSIGQKLTLLLHEYGFDFMKVGEDALVNLETFTLKGNKYKPFRNALNRVEKDGFYFEVVQSPHSQELLNSLEEISNTWLEGRPEKGFSLGYFNKDYFQQAPIALVKNAEHEVVAFANIMPNYEKSIISIDLMRHDKQKIPNGVMDFLFLSLFSYYQEKGYHYFDLGMAPLSGVGRVETSFAKERMAYLVYHFGSHFYSFNGLHKYKKKFTPLWSERYISCSRSSWLICAICALLMEDSKIKIVK	36.13	gnl|BL_ORD_ID|2059|hsp_num:0	2283			1929	2004	defensin
BGC0000085.1|Lankamycin_20 # 52168 # 53337 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.744	BGC0000085.1|Lankamycin_20 	52168	53337	-	Loose	700	391.349	oleD	55.61	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGTTCCGTCGCCACATCGCGATGATCGGCAGCCCCATCGTCAGCCACGTCCTGCCCGGCATCGAGGTCATCCGGGAACTCGTCGCGCGGGGGCACCGGGTGACGTACGCCGACGCCCCCAACGTCGCCGACCTGATCCGGTCCACCGGCGCCGAGTTCGTCCCCTGCCCCACCACCCTGCCCGTCGCCGACAACGACTGGCCGCACGACCCGATCGCGGCGGCCTCCCTCTTCCTCGACGACGCGATGCAGGCCCTGCCCCGGCTGCGCGCCCACTACGACGAGGACCCCGCCGACCTCTACCTCTACGACATCGGCTCCTTCGCGGGCCGCGCCCTCGCCGAGGCGCACCGCCGCCCGCTGGTGCAGCTGTCCCCGAGCTACGTGGCCTGGAAGGGCTACCAGGACGAGGTCGGGGACCTGCTGAATCAGCTGCCGGGCGCCGACGCGTACCGGCGGCGGTTCGCGTCCTGGCTGGCCGGGTGCGGCGCGACCACGCTGGACGTGGACACCTTCACCGGCATGCCCGCCCGCACCGTCGCCCTGATCAGCAGGGCCATGCAGCCCCACGCGGACCGCGTGGACGGCGGCGCCGTGACCTTCGTCGGCCCCTGCCTGGGGGACCGCAGCGAGCAGGGCGGCTGGACCCGGCCGCCGGGCGCCCGGAAGGTGCTGCTGGTCTCCCCCGGCTCCGCCTACACACCGCCCCCGGAGTTCTTCCGCGAGTGCCTGGCGGCCTTCGGCCCGCTGGCCGGCTGGCACGTGGTCCTCCAGATCGGCAGGCGGACCGACGCGCGGGAGCTCGGGGAGATCCCGCCCAATGTCGAGGTGCACCACTGGGTGCCGCAACTCGCGATCCTGGAGCAGGCCGACGCCTTCGTCACCCACGCCGGCATGGGTGGCAGCAGCGAGGGGCTGTACACCGGCGTGCCCATGATCGCCGTGCCGCTGGGCGCCGAGCAGTCCGGCAACGCCGACCGGCTCGTCGCGCTCGGCGTGGCCCGCCGTATCGACACCGCGGACGCCACCGCCGATACTCTGCGCACGGCGCTGCTGGAGCTGACCGCCGACCCGGAGGTCCGCCGCCGCTCGGACGCGCTGCGCGCCGAGGTGCGGGCCGAGGGCGGCACCCGGCGGGCCGCCGACATCATCGAGTCCGCCCTGCCCTAG	MFRRHIAMIGSPIVSHVLPGIEVIRELVARGHRVTYADAPNVADLIRSTGAEFVPCPTTLPVADNDWPHDPIAAASLFLDDAMQALPRLRAHYDEDPADLYLYDIGSFAGRALAEAHRRPLVQLSPSYVAWKGYQDEVGDLLNQLPGADAYRRRFASWLAGCGATTLDVDTFTGMPARTVALISRAMQPHADRVDGGAVTFVGPCLGDRSEQGGWTRPPGARKVLLVSPGSAYTPPPEFFRECLAAFGPLAGWHVVLQIGRRTDARELGEIPPNVEVHHWVPQLAILEQADAFVTHAGMGGSSEGLYTGVPMIAVPLGAEQSGNADRLVALGVARRIDTADATADTLRTALLELTADPEVRRRSDALRAEVRAEGGTRRAADIIESALP	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	93.73	gnl|BL_ORD_ID|1253|hsp_num:0	1367			24	1197	erythromycin; tylosin
BGC0000085.1|Lankamycin_22 # 53765 # 55465 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.734	BGC0000085.1|Lankamycin_22 	53765	55465	+	Loose	1100	745.732	oleB	70.19	3003036	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGCATAACTCCCCCTCCACTTCCTCTTCCCCCGCCCTCGTCGAGGAGCGCCCGGCGGCACCGGACGCCCAGTCGCCGGGCGGCTTCCAGGTCGTCCTGGACGACATCCAGCTCACCCGCGGCAACCGCCGCCTGCTGGACGGCGTGCACCAGTCCGTCGCCCTCGGCGAACGCATCGGCGTCATCGGGGAGAACGGCTGCGGCAAGTCCTCCCTGCTGCGGCTGCTCGCCGGGCTGGACAAGCCCGACGCGGGCCGGGTGCTGGTGCGTGCCCCCGGCGGCACCGGCTACCTGCCGCAGACACCCGAGCTGGCACCCGACGACACCGTGCGGGACGCCATCGACCACGCCCTCGCCGAACTGCGCGCGCTGGAGCAGGAACTGCGCCGCTGCGAAGCGGCGATGGCCGAGGCGGACGGTGACGAACTCACGGACCTGCTGGCCGAGTACGGCAATCTCATGGAGGCCTTCGAGGCGCGCGACCGCTACGCGGCCGACGCCCGCGTGCAGGCCGCCATGCACGGCCTGGGCCTGGCGTCCGTGGACACCACACGGCGGCTGGCCAGCCTGTCCGGCGGTGAGCAGGCGCGGTTGGGCCTGGCCTGTGTGCTGGCCGCCGCACCGCAGCTGATGCTGCTCGACGAGCCCACCAACCACCTGGACCGGAGCGCGCTGGAATGGCTGGAGGAGCACCTGCGCTCCCACCGCGGCAGCGTCCTGGTCGTCTCCCACGACCGCGTCTTCCTGGAGCGGGTCGCGACGGCCCTGTGGGACGTCGACGGCGAACAGCACACCATCCACCGGCACAGCGGTGGTTACGCCGGCTATGTGAAGGCCAAGGCGGCGGCGCGACTGCGCTGGGAGCAGCAGCACCAGGAGTGGAAGGAGGACCTGGCCCGCCAGCGCGAGCTGACGCGCGCCGCGGCGGACCACGCGGCCGCCGGGCCGCGGGGCAACACCGACCGGACGAACGGCCGTCACCAGCGCAGTGTGGAGAAGCAGATCTCGGCGCGCGTGCGCAACGCCAAGGAGCGGCTGCGCCGGCTGGAGGAGAACCCGGTCCCCCGCCCGCCCAGGCCGATGCGCTTCGCCCCCCGGATCCAGGGCGGTGACGCCGCGGGCACCTCGGTGGTCGCCGGGCTGTACCACGTCGAGGTGGCGGACCGGCTGCACGTGCCGGACTTCGAGGTGCGCCCGGCGGAGCGCGTGCTGATCACGGGTCCGAACGGAGCCGGCAAGAGCACCCTGCTGCGGGTGCTGGTCGGGGATCTGGAACCGGACCGGGGCACGAGCGTCCATCCGGCGCGCACCGGCTGGCTGCCGCAGGAGACCCCGGTGACCTCGCCCGGACTCAGCCTCCTGGAGGCGTTCAGCCAGGGGCTGCCCGGTGACGCCGAGGCACATCGCGGGGCGCTGCTGGGCCTCGGGCTGTTCCGGCCGTCGGATCTGGCCACCGCGGTGGGCCGGCTCTCCGTCGGCCAGCGCCGGCGGCTCGCCCTGGCCCGTCTCCTGCACGAGCCGGTGGACCTGCTGGTGCTCGACGAGCCGACGAACCATCTGTCGCCGGCGCTGGTGGAAGACCTCGAAGAGGCCCTGTCGCACTACCGCGGGGCACTGGTCGTCGTCTCCCACGACCGCATGCTCGAAAGGCGGTTCAACGGCCGCACGGTGCGGCTGGAGGACGGCTCGATCCGCGACTGA	MHNSPSTSSSPALVEERPAAPDAQSPGGFQVVLDDIQLTRGNRRLLDGVHQSVALGERIGVIGENGCGKSSLLRLLAGLDKPDAGRVLVRAPGGTGYLPQTPELAPDDTVRDAIDHALAELRALEQELRRCEAAMAEADGDELTDLLAEYGNLMEAFEARDRYAADARVQAAMHGLGLASVDTTRRLASLSGGEQARLGLACVLAAAPQLMLLDEPTNHLDRSALEWLEEHLRSHRGSVLVVSHDRVFLERVATALWDVDGEQHTIHRHSGGYAGYVKAKAAARLRWEQQHQEWKEDLARQRELTRAAADHAAAGPRGNTDRTNGRHQRSVEKQISARVRNAKERLRRLEENPVPRPPRPMRFAPRIQGGDAAGTSVVAGLYHVEVADRLHVPDFEVRPAERVLITGPNGAGKSTLLRVLVGDLEPDRGTSVHPARTGWLPQETPVTSPGLSLLEAFSQGLPGDAEAHRGALLGLGLFRPSDLATAVGRLSVGQRRRLALARLLHEPVDLLVLDEPTNHLSPALVEDLEEALSHYRGALVVVSHDRMLERRFNGRTVRLEDGSIRD	MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE	99.47	gnl|BL_ORD_ID|1272|hsp_num:0	1388			0	1701	oleandomycin
BGC0000085.1|Lankamycin_23 # 55655 # 56431 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.678	BGC0000085.1|Lankamycin_23 	55655	56431	+	Loose	310	27.7202	Type B NfxB	28.99	3004060	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCAAGGACGGCTTCACCGACCCGCGCATCGTTCCCCACGAGTCGGAGCAGGAACGGGACGCGCGTGAGCGGCTCACCAAGCTCCTCGTGGACAGCCCCATCCCTCCGAAGTACCTGATCGACAACCTGCCCGTCTATCTGCGCCGCCATCAGCTCGCCGATCTGCTCAGCATGGACGCGCTGTACCGGATGCTGCCCGAGATACCGGGCGTCATCATGGAGTTCGGGGTACTGCACGGCCGTCACCTGGCCACGCTCACGGCCCTGCGCACGTCCTACGAGCCGTACAACTCGCTGCGCCGCATCATCGGCTTCGACACCTTCACGGGCTTCCCCGACGACATCGACGACGTGGACAAGGTCAGCACGAGCGCCCATCCCGGACGCTTCGCGGTGCCGGAGGACGAGGTCGGCCATCTGCGCGAGGTCCTGGCGGCGCACGAGGCCGGCGAGCCCTTCGGGCACACGCAGCGTTCCTTCGTCGTCCAGGGCGACGTACGCGAGACGGTGCCGCAGTACCTGGCGGACAACCCGGAGACGGTCATCGCCATGGCCTACTTCGACCTGGATCTCTACCAGCCGACCAGGGAACTGCTGGAGGCGATCCGCCCGCATCTGACCAAGGGGAGCATCCTCGCGTTCGACGAGCTGGCCCACCCCAAGTGGCCCGGTGAGACCACCGCGCTGCGGGAGGTCTTCGGCCTGGACCACGCGCCGTTGCGCCAGCTGCCCGGCCGCGAGCCGCCGGTCATCTACCTGAAGTGGGGCGAGTGA	MAKDGFTDPRIVPHESEQERDARERLTKLLVDSPIPPKYLIDNLPVYLRRHQLADLLSMDALYRMLPEIPGVIMEFGVLHGRHLATLTALRTSYEPYNSLRRIIGFDTFTGFPDDIDDVDKVSTSAHPGRFAVPEDEVGHLREVLAAHEAGEPFGHTQRSFVVQGDVRETVPQYLADNPETVIAMAYFDLDLYQPTRELLEAIRPHLTKGSILAFDELAHPKWPGETTALREVFGLDHAPLRQLPGREPPVIYLKWGE	MTLISHDERLIKALAVAIVDRPRATLKELAEAAGVSKATLHRFCGTRDNLVQMLEDHGETVLNQIIQACDLEHAEPLEALQRLIKEHLTHRELLVFLVFQYRPDFLDPHGEGARWQSYLEALDAFFLRGQQKGVFRIDITAAVFTELFITLVYGMVDAERRGRAASSNSAHTLEQMFLHGASNPARS	137.97	gnl|BL_ORD_ID|2342|hsp_num:0	2693			81	288	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
BGC0000085.1|Lankamycin_25 # 57154 # 58584 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.674	BGC0000085.1|Lankamycin_25 	57154	58584	-	Loose	900	30.8018	AAC(6')-Ie-APH(2'')-Ia bifunctional protein	35.29	3002597	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	aminoglycoside bifunctional resistance protein	ATGCCCGCTGAGTTCACCGACTTCAAGGTCGCCGACCTGTCCCTGGCCGAGTTCGGCCGCAAGGAGATCACCCTCGCCGAGCACGAGATGCCCGGCCTGATGGCGATCCGCAAGGAGTACGCCGGGGAGCCGCCGCTGGCCGGCGCCCGGATCACCGGCTCCCTGCACATGACCGTGCAGACCGCCGTGCTGATCGAGACCCTGGTCGCCCTCGGCGCCGAGGTCCGCTGGGCGTCCTGCAACATCTTCTCCACCCAGGACCACGCGGCCGCCGCCATCGCCGTCGGCCCGGACGGCACGCCGGACAACCCTCGGGGCGTCCCGGTCTTCGCCTGGAAGGGCGAGACCCTGGAGGAGTACTGGTGGTGCACCGAGCAGGCGCTGACCTGGCCGGACAGCCCCACCGGCGGCCCGAACATGATCCTGGACGACGGCGGCGACGCCACCCTCCTCGTCCACAAGGGCGTCGAATACCGCAAGACCGGTGAGCTGCCGCCGGCCGACAACGAGGAACTGGCCGCCGTGGCCGCCCTGCTGAAGGCGAGCAACCTCGACTGGACCGGCATCGCCTCCGAGATCCGCGGGGTGACGGAGGAGACCACGACGGGTGTGCACCGGTTGTACGAGATGCAGCGTGACGGTGTGCTGCTGTTCCCGGCGATCAATGTGAACGACGCGGTGACGAAGTCGAAGTTCGACAACAAGTACGGGTGCCGGCATTCGCTGGTGGACGGCATCAACCGTGCGACGGACGTGCTGATCGGCGGGAAGACCGCTGTGGTGTGCGGGTACGGTGATGTGGGCAAGGGGTGTGCGGAGTCCCTGCGGGGGCAGGGCGCGCGGGTGATCGTCACCGAGATCGACCCGATCTGCGCGCTGCAGGCGGCGATGGACGGTTATCAGGTGACGACGCTGGACGAGGTCGTCGAGACGGCGGACATCTTCGTCACCACGACGGGCAACAAGGACATCATCATGGCCTCGGACATGGCCAGGATGAAGCACCAGGCGATCGTGGGGAACATCGGTCACTTCGACAACGAGATCGACATGGCCGGTCTGGCGCGGGTTCCGGGCATCGTCAAGGACGAGGTCAAGCCGCAGGTCCACACGTGGACGTTCCCGGACGGCAAGGTGATCATCGTGCTGTCCGAGGGCCGTCTGCTGAACCTGGGCAACGCGACCGGGCACCCGTCGTTCGTGATGTCGAACTCCTTCGCGGACCAGACGCTGGCGCAGATCGAGCTGTTCACCAAGCCCGACCAGTACCCGACCGGCGTGTACACGCTGCCCAAGCACCTGGACGAGAAGGTCGCCCGTCTCCACCTCGACGCCCTCGGCGTCAAGCTGACCACGCTGCGCCCGGAGCAGGCGGCGTACATCGGAGTCGAGGTCGAGGGCCCGTACAAGCCGGACCACTACCGCTACTGA	MPAEFTDFKVADLSLAEFGRKEITLAEHEMPGLMAIRKEYAGEPPLAGARITGSLHMTVQTAVLIETLVALGAEVRWASCNIFSTQDHAAAAIAVGPDGTPDNPRGVPVFAWKGETLEEYWWCTEQALTWPDSPTGGPNMILDDGGDATLLVHKGVEYRKTGELPPADNEELAAVAALLKASNLDWTGIASEIRGVTEETTTGVHRLYEMQRDGVLLFPAINVNDAVTKSKFDNKYGCRHSLVDGINRATDVLIGGKTAVVCGYGDVGKGCAESLRGQGARVIVTEIDPICALQAAMDGYQVTTLDEVVETADIFVTTTGNKDIIMASDMARMKHQAIVGNIGHFDNEIDMAGLARVPGIVKDEVKPQVHTWTFPDGKVIIVLSEGRLLNLGNATGHPSFVMSNSFADQTLAQIELFTKPDQYPTGVYTLPKHLDEKVARLHLDALGVKLTTLRPEQAAYIGVEVEGPYKPDHYRY	MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD	99.37	gnl|BL_ORD_ID|4823|hsp_num:0	1814			1116	1218	dibekacin; amikacin; sisomicin; netilmicin; kanamycin A; tobramycin; gentamicin A; 2'-N-ethylnetilmicin; 5-episisomicin; gentamicin
BGC0000085.1|Lankamycin_26 # 58574 # 59434 # -1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=9bp;gc_cont=0.715	BGC0000085.1|Lankamycin_26 	58574	59434	-	Loose	500	28.1054	blaC	31.46	3007182	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam; penem	antibiotic inactivation	class A Mycobacterium tuberculosis bla beta-lactamase	ATGACGACGTTCTCCTTCGAGTTCTTCCCGCCGAAGACGGCCGCGGGCGAGCAGGCGCTGTGGCGGGCCGTCCGCCGCATCGAACCACTGGCGCCCGACTTCGTGTCCGTCACCTACGGCGCGGGCGGATCCTCGCGGGAGCGCACCATCCAGCTCACCCAGCGGATGGTGACCGAGACGACGCTGCGCCCCGTGGCACACCTGACCGCCGTCGGGCACTCGACCGCCGAACTGCGCCGCATCATCGGCCAGTACGCGGACGCCGGGGTGCGCGACGTGCTCGTCCTGCGCGGCGACCCGCCCGGCGACCCGAGGGGGCCGTGGCAGCCGCACCCCGAGGGCCTCACCCACGCCTGCCAACTGGTCGAACTGGTGCGGTCGCTCGGGCAGTTCACCATCGGGGTGGCGGCGTTCCCGGAAAGGCACCCGCGCTCGCCCGACTGGGACAGCGACATCCGGCACTTCGTGGCCAAGTGCCGCGCGGGCGCGGACTACGCGATCACCCAGATGTTCTTCGACGTCGAGGACTACCTGCGGCTGCGCGACCGTGTCGAGGCGGCCGGCTGTACGACGCCGATCATCCCGGAGATCATGCCGGCCACGGACGTCCGGCAGATCCGGCGCTTCGCCGAACTCTCCGACGCGGCCTTCCCGGAGGACCTGGCCCACCGCCTCGAAGCCGCCCGCGAGCGGCCCGACGACGCATACCGGATCGGGGTCGAGCACGCCACCGCCATGGCGGACCGGCTGCTCGCCGAGGGCGCCCCCGGCCTGCACTACATCACGCTCAACAAGTCCACGGCAGCCTTGGACATCCACCGCAACGTACTGAGCCGCTCAAGGAGCCTCCATGCCCGCTGA	MTTFSFEFFPPKTAAGEQALWRAVRRIEPLAPDFVSVTYGAGGSSRERTIQLTQRMVTETTLRPVAHLTAVGHSTAELRRIIGQYADAGVRDVLVLRGDPPGDPRGPWQPHPEGLTHACQLVELVRSLGQFTIGVAAFPERHPRSPDWDSDIRHFVAKCRAGADYAITQMFFDVEDYLRLRDRVEAAGCTTPIIPEIMPATDVRQIRRFAELSDAAFPEDLAHRLEAARERPDDAYRIGVEHATAMADRLLAEGAPGLHYITLNKSTAALDIHRNVLSRSRSLHAR	MRNRGFGRRELLVAMAMLVSVTGCARHASGARPASTTLPAGADLADRFAELERRYDARLGVYVPATGTTAAIEYRADERFAFCSTFKAPLVAAVLHQNPLTHLDKLITYTSDDIRSISPVAQQHVQTGMTIGQLCDAAIRYSDGTAANLLLADLGGPGGGTAAFTGYLRSLGDTVSRLDAEEPELNRDPPGDERDTTTPHAIALVLQQLVLGNALPPDKRALLTDWMARNTTGAKRIRAGFPADWKVIDKTGTGDYGRANDIAVVWSPTGVPYVVAVMSDRAGGGYDAEPREALLAEAATCVAGVLA	93.16	gnl|BL_ORD_ID|4814|hsp_num:0	5800			552	783	cefoxitin; amoxicillin; cefalotin; temocillin; ticarcillin
BGC0000085.1|Lankamycin_27 # 59431 # 62880 # -1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=GGGGG;rbs_spacer=9bp;gc_cont=0.690	BGC0000085.1|Lankamycin_27 	59431	62880	-	Loose	500	30.8018	OXA-816	27.35	3006015	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGACGGGCGCCGAGACCCTGAGGGAGGCGCTCGCCACCCGTGTGGTGGTCGCCGACGGAGCGATGGGCACCATGCTCCAGGCCCAGGACCCGACCCTGGACGACTTCCAGCAGCTGGAGGGCTGCAACGAGATCCTCAACGTCACCCGACCGGATATCGTCCGCTCGGTGCACGAGGCGTATTTCGCGGTCGGTGTCGACTGTGTGGAGACCAATACCTTCGGTGCCAACCACGCGGCCCTCGGCGAGTACGACATCTCCGACCGTGTCCACGAGCTCTCCGCGGCCGGGGCCCGTGTGGCCCGCGAGGTGGCCGATGAGTTCACGGCCCGTGACGGCCGCGCTCGCTGGGTGCTCGGTTCGATGGGGCCCGGCACCAAGCTGCCCACCCTCGGTCACGCCCCGTACCGCACTCTGCGCGACGCCTACCAGGCGAACGCGGAGGGCCTGGTCGAGGGCGGCGCCGACGCCCTCTTGGTGGAGACCACCCAGGACCTGTTGCAGACGAAGGCAGCGGTGCTCGGCGCCCGGCGCGCCCTGGCAGCGGCTGGAGCGGACTTGCCGGTGATCGTCTCGGTGACGGTCGAGACCACCGGCACGATGCTCCTCGGTTCGGAGATCGGCGCGGCGCTGACGGCTCTGGAGCCGCTGGGCATCGACATGATCGGTCTGAACTGCGCCACCGGTCCGGCCGAGATGAGCGAGCATCTGCGCTATCTCGCCCGCAACGCGCGCGTCCCGTTGTCCTGTATGCCGAACGCCGGTCTGCCGGTCCTGGGCAAGGACGGCGCCCACTACCCACTCTCGCCCGGTGAACTGGCGGAAGCCCAGGGGACGTTCGTGCGGGAGAACGGGGTGTCACTGGTCGGCGGGTGCTGCGGTACGACCCCCGAACACCTGCGTCAGGTGGTGGAGCGCGTGCGGGGTCTGGCCCCGTCGGCGCGTGATCCGCGTCCGGAGGCAGGGGCGGCGTCGTTGTATCAGTCGGTGCCGTTCCGGCAGGACACCTCGTATCTGGCGATCGGTGAGCGGACGAACGCGAACGGGTCGAAGAAGTTCCGTGAGGCGATGCTGGAGGCCCGCTGGGACGACTGTGTGGAGATCGCGCGGGAGCAGATCCGCGAGGGCGCGCACATGCTGGATCTGTGTGTGGACTACGTCGGTCGTGACGGTGTGGCGGACATGGCGGAGCTGGCCGGGCGGCTGGCGACGGCGTCGACGCTGCCGATCGTGCTGGATTCCACCGAGGTCGATGTCATCGAGGCGGGTCTGGAGCGCCTGGGCGGCCGTGCGGTGATCAATTCGGTGAACTACGAGGACGGGGACGGTCCCGAGTCGCGGTTCGCGAGGGTCACGGCGCTGGCGCGGGAGCATGGTGCGGCGTTGATCGCGTTGACGATCGACGAGGAGGGTCAGGCCCGCACGGCCGGGCACAAGGTCGCGATCGCGGAGCGTCTGATCGCGGATCTGACCGGGAACTGGGGGATCCGCGAGTCGGACATCCTGATCGACACGCTGACGTTCACGATCTGCACGGGTCAGGAGGAGTCCCGCGGGGACGGTGTCGCCACGATCGAGGCGATCCGCGAGCTCAAGCGCCGTCATCCGCGGGTGCAGACCACGCTCGGGTTGTCGAACATCTCCTTTGGTCTGAACCCGGCCGCCCGCATCCTCCTCAACAGCGTCTTCCTGGACGAGTGTGTGAAGGCGGGCCTGGACTCGGCGATCGTGCACGCCTCGAAGATCCTCCCCATCGCGCGTTTCAGCGAGGAAGAGGTGCAGACGGCGCTCGACCTCATCTACGACCGCCGCGCCGAGGGCTACGACCCGCTCCAGAAGCTGATGCAGCTGTTCGAGGGCGCGACGGCGAAGTCGCTGAAGGCGGGCAAGGCCGAGGAGCTGGCCGCGCTGCCGCTGGAGGAGCGGCTCAAGCGGCGGATCATCGACGGCGAGCGCAACGGTCTGGAGGCCGACCTGGACACCGCGCTCCGGGAGCGTCCCGCTCTGGACATCGTCAACGAGACGCTGCTGGACGGGATGAAGGTCGTCGGTGAGCTGTTCGGGTCGGGGCAGATGCAGCTGCCGTTCGTGCTCCAGTCCGCCGAGGTGATGAAGGCCGCGGTCGCCCATCTGGAGCCGCACATGGAGAAGTCGGACGCGGACGGCAAGGGCACCATCGTGCTGGCCACCGTGCGCGGTGACGTCCATGACATCGGCAAGAACCTGGTCGACATCATCCTGTCGAACAACGGCTACAACGTGGTCAATCTGGGCATCAAGCAGCCGGTCTCCGCGATCCTGGAGGCCGCCGAGGAACACCGCGCGGACGTGATCGGGATGTCCGGGCTGCTGGTGAAGTCCACGGTGATCATGAAGGAGAACCTGGAGGAACTCAACCAGCGCGACCTGGCCGGCACCTACCCCGTCATCCTCGGCGGCGCCGCACTGACCAGGGCATACGTCGAACAGGACCTCCACGAGATCTACCAGGGAGAAGTCCGCTACGCCCGTGACGCGTTCGAGGGTCTGCGTCTGATGGACGCGTTGATCGGCGTCAAGCGGGGCGTGCCCGGCGCGAAACTGCCCGAACTGAAGCAGCGGCGGGTAGCCGCGCGGCGGGCGGTCCCGGAGGAGCCCGCGGAGGCCGGCCGCTCCGACGTCGCCACCGACAACCCCGTGCCGGCACCACCGTTCTGGGGCACCCGTGTCGTCAAGGGCATCCAGCTCAGGGAGTACGCCTCCTGGCTCGACGAGGGCGCCCTGTTCAAGGGCCAGTGGGGGCTCAAGGGCGAGACCATCGAGGGCGAGGGGCGGCCCCGGCTGCGCATGTGGCTCGACCGGCTGCTGACGGGGAACCTGCTGGAAGCGGCCGTGGTCCACGGCTACTTCCCCTGCGTCTCGAAGGACGACGACCTGATCGTCCTGGACGAACACGGCAACGAGCGCACCCGGTTCACCTTCCCCCGCCAGCGCCGCGGCCGGCGCCTGTGCCTGGCCGACTTCTTCCGCCCGCAGGAGTCGGGGGAGACCGATGTCGTCGGCTTCCAGGTCGTCACCGTCGGCTCCCGCATCGGCGCGGAGACCGCCAAGCTGTTCGAGGCCGACGCCTACCGCGACTACCTCGAACTGCACGGCCTGTCCGTCCAGTTGGCCGAGGCACTGGCCGAGTACTGGCACGCCCGCGTGCGTGGCGAACTCGGCATCGGCGGCAGCGACCCGGCCGCCATGGAGGGCATGTTCCGCACGGAGTACCAGGGCTGCCGCTACTCGTTCGGCTACCCGGCCTGCCCGGACCTGGAGGACCGCGCCAAGATCGCCGAGCTGCTGCGGCCCGAGCGGATCGGCGTCCACCTCTCCGAGGAGTTCCAGCTCCACCCGGAGCAGTCCACCGACGCCCTCGTCGTCCACCACCCCGAGGCCGGCTACTTCAACGCGGGAGGCCGCGCATGA	MTGAETLREALATRVVVADGAMGTMLQAQDPTLDDFQQLEGCNEILNVTRPDIVRSVHEAYFAVGVDCVETNTFGANHAALGEYDISDRVHELSAAGARVAREVADEFTARDGRARWVLGSMGPGTKLPTLGHAPYRTLRDAYQANAEGLVEGGADALLVETTQDLLQTKAAVLGARRALAAAGADLPVIVSVTVETTGTMLLGSEIGAALTALEPLGIDMIGLNCATGPAEMSEHLRYLARNARVPLSCMPNAGLPVLGKDGAHYPLSPGELAEAQGTFVRENGVSLVGGCCGTTPEHLRQVVERVRGLAPSARDPRPEAGAASLYQSVPFRQDTSYLAIGERTNANGSKKFREAMLEARWDDCVEIAREQIREGAHMLDLCVDYVGRDGVADMAELAGRLATASTLPIVLDSTEVDVIEAGLERLGGRAVINSVNYEDGDGPESRFARVTALAREHGAALIALTIDEEGQARTAGHKVAIAERLIADLTGNWGIRESDILIDTLTFTICTGQEESRGDGVATIEAIRELKRRHPRVQTTLGLSNISFGLNPAARILLNSVFLDECVKAGLDSAIVHASKILPIARFSEEEVQTALDLIYDRRAEGYDPLQKLMQLFEGATAKSLKAGKAEELAALPLEERLKRRIIDGERNGLEADLDTALRERPALDIVNETLLDGMKVVGELFGSGQMQLPFVLQSAEVMKAAVAHLEPHMEKSDADGKGTIVLATVRGDVHDIGKNLVDIILSNNGYNVVNLGIKQPVSAILEAAEEHRADVIGMSGLLVKSTVIMKENLEELNQRDLAGTYPVILGGAALTRAYVEQDLHEIYQGEVRYARDAFEGLRLMDALIGVKRGVPGAKLPELKQRRVAARRAVPEEPAEAGRSDVATDNPVPAPPFWGTRVVKGIQLREYASWLDEGALFKGQWGLKGETIEGEGRPRLRMWLDRLLTGNLLEAAVVHGYFPCVSKDDDLIVLDEHGNERTRFTFPRQRRGRRLCLADFFRPQESGETDVVGFQVVTVGSRIGAETAKLFEADAYRDYLELHGLSVQLAEALAEYWHARVRGELGIGGSDPAAMEGMFRTEYQGCRYSFGYPACPDLEDRAKIAELLRPERIGVHLSEEFQLHPEQSTDALVVHHPEAGYFNAGGRA	MNKYFTCYVVASLFLSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFIAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNTEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII	420.88	gnl|BL_ORD_ID|4050|hsp_num:0	5120			333	630	cloxacillin; oxacillin; cefalotin
BGC0000085.1|Lankamycin_28 # 62877 # 63008 # -1 # ID=1_28;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.788	BGC0000085.1|Lankamycin_28 	62877	63008	-	Loose	850	21.9422	baeS	45.45	3000829	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GGTTCCCAGGCGTACGAGGCCGCCCCCGCCCGGCTCCTCGCCGCCCTCACCACCGCGTACGGCGCCGACGCCGCCGCGGAGATCGCGCCCGCCCTGCCGGCCACCGTGTCCGAAGGGGGCGAGGCGTCGTGA	GSQAYEAAPARLLAALTTAYGADAAAEIAPALPATVSEGGEAS	MKFWRPGITGKLFLAIFATCIVLLISMHWAVRISFERGFIDYIKHGNEQRLQLLSDALGEQYAQHGNWRFLRNNDRFVFQILRSFEHDNSEDKPGPGMPPHGWRTQFWVVDQNNKVLVGPRAPIPPDGTRRPILVNGAEVGAVIASPVERLTRNTDINFDKQQRQTSWLIVALATLLAALATFLLARGLLAPVKRLVDGTHKLAAGDFTTRVTPTSEDELGKLAQDFNQLASTLEKNQQMRRDFMADISHELRTPLAVLRGELEAIQDGVRKFTPETVASLQAEVGTLTKLVDDLHQLSMSDEGALAYQKAPVDLIPLLEVAGGAFRERFASRGLKLQFSLPDSITVFGDRDRLMQLFNNLLENSLRYTDSGGSLQISAGQRDKTVRLTFADSAPGVSDDQLQKLFERFYRTEGSRNRASGGSGLGLAICLNIVEAHNGRIIAAHSPFGGVSITVELPLERDLQREV	9.21	gnl|BL_ORD_ID|913|hsp_num:0	986			909	975	novobiocin
